Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 48(2); 2016 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
Chang-Mo Oh, MD, PhD1,2, Young-Joo Won, PhD1,2,3,, Kyu-Won Jung, MS1,2, Hyun-Joo Kong, MS1,2, Hyunsoon Cho, PhD1,2,3, Jong-Keun Lee, MD, PhD1,2, Duk Hyoung Lee, MD, PhD2,3, Kang Hyun Lee, MD, PhD1, The Community of Population-Based Regional Cancer Registries,*
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2016;48(2):436-450.
DOI: https://doi.org/10.4143/crt.2016.089
Published online: March 3, 2016

1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2National Cancer Control Institute, National Cancer Center, Goyang, Korea

3Department of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD  The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea  Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
• Received: February 29, 2016   • Accepted: March 2, 2016

Copyright © 2016 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 36,285 Views
  • 1,155 Download
  • 275 Web of Science
  • 275 Crossref
  • 279 Scopus
prev next
  • Purpose:
    This study described the 2013 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality.
  • Materials and Methods:
    Cancer incidence data from 1999-2013 were obtained from Korea National Cancer Incidence Database and followed until December 31, 2014. Mortality data from 1983-2013 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed since 1999. Crude, and age-standardized and 5-year relative survival rates were also calculated.
  • Results:
    In 2013, a total of 225,343 and 75,334 Koreans were newly diagnosed and died from cancer, respectively. The age-standardized rates for cancer incidence and mortality in 2013 were 290.5 and 87.9 per 100,000, respectively. The age-standardized cancer incidence rate increased 3.1% annually between 1999 and 2013. However, the overall cancer incidence rates have decreased slightly in recent years (2011 to 2013). The age-standardized rate for all-cancer mortality has decreased 2.7% annually since 2002. Overall, the 5-year relative survival rate for people diagnosed with cancer between 2009 and 2013 was 69.4%, which represents an improved survival rate as compared with 41.2% for people diagnosed between 1993 and 1995.
  • Conclusion:
    Age-standardized cancer incidence rates have decreased between 2011 and 2013; mortality rates have also declined since 2002, while 5-year survival rates have improved remarkably from 1993-1995 to 2009-2013 in Korea.
Cancer is a major life-threatening disease worldwide. GLOBOCAN 2012 estimated that approximately 14.1 million patients were newly diagnosed with cancer and 8.2 million people died from cancer [1]. The global burden of cancer is expected to grow rapidly due to population growth and aging [2].
In Korea, cancer accounts for one in four deaths (27.6%) and more than 200,000 new cancer cases were diagnosed in 2012 [3]. Cancer incidence and deaths are expected to increase with increasing population aging and westernized lifestyles [4]. In addition, the economic burden of cancer in Korea increased about 1.8-fold, from $11,424 to $20,858 million, between 2000 and 2010 [5].
In this context, cancer statistics are the most important indicator to assess the national cancer burden and establish cancer prevention and control strategies. This article aims to provide nationwide cancer statistics including cancer incidence, survival, prevalence, and mortality in 2013.
1. Data sources
The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980. Until 1998, the KCCR registered cancer cases from hospitals in order to determine cancer incidence, with increasing coverage. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a hospital-based KCCR database with data from regional cancer registry programs. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually. KCCR has been described in more detail elsewhere [6].
The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, site-specific cancer registries, and additional medical chart review. The KNCI DB includes patient case information including age, sex, region, date of birth, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, and stage. The completeness of cancer incidence data for 2013 was estimated to be 97.8% based on the method proposed by Ajiki et al. [7]. Mid-year population and cancer mortality data from 1983 to 2013 were obtained from Statistics Korea (http://kosis.kr) [8]. To ascertain vital status and calculate survival and prevalence, the KNCI DB was linked to mortality data.
2. Classification
All incident cancer cases were collected and registered according to the International Classification of Diseases for Oncology, 3rd edition [9]. The all cancer cases were reported according to the International Classification of Diseases, 10th edition (ICD-10) [10] and categorized into 24 cancer types.
3. Statistical analyses
Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The crude rate was calculated as the total number of incidence/mortality cases divided by the mid-year population of the specified years. The sum of the expected age-specific rates was obtained by multiplying the age-specific incidence rates among study population by the proportion of population in the corresponding age-specific groups among standard population. Next, the age-standardized incidence rates per 100,000 people were calculated as the sums of the expected age-specific rates divided by the sum of the standard population [11]. We used Segi’s world standard population to calculate the age-standardized rates [12]. Age-specific rates were also calculated for given age groups. The cumulative risk of developing cancer from birth to life expectancy were calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows [13]:
Cumulative risk of developing cancer from birth to life expectancy=100×(1-e-cumulative rate100)
Trends in incidence/mortality rates were summarized as annual percentage change (APC). APC is the average percentage change of rates and is calculated as follows [11]:
APC=Ry+1-RyRy×100=(eb1-1)×100
, where log(Ry)=b0+b1y,
log(Ry) is the natural log transformed age standardized rates.
y=year, b0=intercept, b1=slope
The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up (December 31, 2014). Relative survival rates were calculated using the Ederer II method [14] with some minor corrections, based on an algorithm by Paul Dickman [15]. The 5-year relative survival rates were calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2009-2013.
Prevalent cases were defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed between 1999 and 2013. Limited-duration prevalences were calculated using SEER*Stat software to calculate 1-, 3-, and 5-year prevalent cases.
P-values less than 0.05 were considered statistically significant. SEER*Stat 8.2.1 (National Cancer Institute, Bethesda, MD) and SAS 9.3 (SAS Institute Inc., Cary, NC) were used to calculate the incidence, mortality, survival, and prevalence and to perform the statistical analyses.
1. Incidence
A total of 225,343 cases were newly diagnosed with cancer during the study period (Table 1). Of these cases, 113,744 (50.5%) were men and 111,599 cases (49.5%) were women. Thyroid cancer was the most commonly diagnosed cancer in 2013, and followed by stomach, colorectal, lung, and breast cancer in 2013. The overall cumulative risk of developing cancer from birth to life expectancy was 36.6%. However, the cumulative risk of developing cancer from birth to life expectancy was higher in men (38.3%) than in women (35.0%).
The total CR and ASR for overall cancer incidence in 2013 were 445.7 and 290.5 per 100,000, respectively (Table 2). According to sex, CRs for all sites combined were 449.9 per 100,000 in men and 441.5 per 100,000 in women. The ASRs were 316.5 and 281.8 per 100,000 in men and women, respectively. Stomach cancer (CR, 80.2 per 100,000) was the most common cancer in men, followed by colorectal (CR, 65.6 per 100,000), lung (CR, 64.0 per 100,000), liver (CR, 47.9 per 100,000), and prostate cancer (CR, 37.6 per 100,000). These five cancers accounted for 65.6% of newly diagnosed cancer in men during the study period. In contrast, thyroid cancer (CR, 134.9 per 100,000) was the most common cancer among women, followed by breast (CR, 68.2 per 100,000), colorectal (CR, 43.6 per 100,000), stomach (CR, 39.2 per 100,000), and lung cancer (CR, 27.7 per 100,000). These five cancers accounted for 71.0% of cases in women.
2. Mortality
In 2013, cancer was the most common leading cause of death in Korea (Table 3). The total number of deaths from cancer was 75,334 in 2013, accounting for 28.3% of all deaths (Table 3). According to sex, 62.5% and 37.5% of cancer deaths occurred in men and women, respectively (Table 1).
The total CR and ASR for cancer deaths were 149.0 and 87.9 per 100,000, respectively, in 2013 (Table 4). The total CR and ASR for cancer deaths per 100,000 were higher among men (ASR, 130.1) than in women (ASR, 57.5).
According to the cancer sites, lung cancer (CR, 49.5 per 100,000) was the leading cause of death in men, followed by liver (CR, 33.3 per 100,000), stomach (CR, 23.7 per 100,000), colorectal (CR, 18.4 per 100,000), and pancreatic cancer (CR, 10.3 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.4 per 100,000), colorectal (CR, 14.0 per 100,000), stomach (CR, 12.6 per 100,000), liver (CR, 11.8 per 100,000), and breast cancer (CR, 8.8 per 100,000)
3. Trends in cancer incidence and mortality rates
The trends in overall cancer incidence and mortality rates by sex are shown in Fig. 1. The ASR for all-cancer incidence increased 3.1% annually from 1999 to 2013 (Table 5, Fig. 1). However, in recent years, ASR for all-cancer incidence has decreased slightly, from 303.8 per 100,000 in 2011 to 290.5 per 100,000 in 2013 (APC, –2.1%). In contrast, ASR for all-cancer mortality has decreased 2.7% annually from 2002 to 2013 (Fig. 1).
The ASR for all-cancer incidence in women (APC, 5.1%; 95% confidence interval [CI], 4.6 to 5.6) has increased more rapidly than that in men (APC, 1.3%; 95% CI, 1.0 to 1.6) (Tables 6 and 7) since 1999, whereas ASR for all-cancer mortality in men (APC, –3.1%; 95% CI, –3.3 to –2.8) has decreased faster than that in women (APC, –2.2%; 95% CI, –2.5 to –1.9) since 2002 (Fig. 1).
4. Trends in cancer incidence and mortality rates by common cancer sites
Between 1999 and 2013, ASR for thyroid cancer incidence has been most notably increased in both men (APC, 22.7%) and women (APC, 20.6%) (Tables 6 and 7). Among men, the age-standardized incidence rates of prostate (APC, 10.7%) and colorectal cancer (APC, 5.0%) have increased from 1999 to 2013, while the age-standardized incidence rates of liver (APC, –2.2%), lung (APC, –1.0%), and stomach cancer (APC, –0.8%) have decreased from 1999 to 2013 (Table 6, Fig. 2). Among women, the age-standardized incidence rates of breast (APC, 5.9%), colorectal (APC, 3.7%), and lung (APC, 1.7%) have increased from 1999 to 2013 (Table 7). However, the age-standardized incidence rates of cervical (APC, –3.9%), liver (APC, –1.8%), and stomach cancer (APC, –0.7%) in women have decreased from 1999 to 2013.
The age-standardized mortality rate of stomach cancer has decreased continuously in both sexes (Fig. 3). Although the age-standardized mortality rate of colorectal cancer increased from 1983 to 2003, the mortality rate of colorectal cancer has leveled off since 2003 in men. For women, the age-standardized mortality of colorectal cancer increased from 1983 to 2004, but the mortality rate has subsequently decreased. For both sexes, the age-standardized mortality of lung cancer increased from 1983 to 2002, and the mortality rates for lung cancer decreased. The mortality rates for uterine cancer in women and liver cancer in both sexes have continuously decreased since the mid-1990s. However, the breast cancer mortality rate in women and the prostate cancer mortality rate in men showed increasing trends during the observation period (1983-2013).
5. Age-specific incidence rates
According to age group, leukemia was the most commonly diagnosed cancer among children between 0-14 years of age, while thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age (Table 8). For men, the incidence rate of cancer increased with age (Fig. 4A). Stomach cancer was the most commonly diagnosed cancer among men aged 35 and 64 years old, while lung cancer was the most common among elderly men aged ≥ 65 years. In contrast, thyroid cancer was most commonly diagnosed among women aged 35 and 64 years, while colorectal cancer was most common among elderly women aged ≥ 65 years. Thyroid and breast cancer showed inverted U-shaped incidence rates by age (Fig. 4B).
6. Survival rates
The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 69.4% in 2009-2013 (Table 9, Fig. 5A). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1993-1995 to 2009-2013 (Fig. 5B).
The 5-year relative survival rate in 2009-2013 for all cancer combined was 61.0% in men and 77.7% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2009-2013 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 9.4% in both sexes in 2009-2013.
When compared to the 5-year relative survival rate for 1993-1995, prostate cancer diagnosed from 2009 to 2013 showed the most outstanding improvement, followed by stomach cancer, leukemia, ‘lip, oral cavity, and pharynx’ and colorectal cancer in men. Among women, stomach cancer diagnosed during 2009-2013 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and 1995, followed by leukemia, non-Hodgkin’s lymphoma, colorectal cancer, and kidney cancer.
7. Prevalence rates
A total of 1,370,049 cancer prevalent cases were identified on January 1, 2014 (Table 1). Of these cases, 603,524 (44.1%) were men and 766,525 (55.9%) were women. The crude and age-standardized prevalence rates for cancer overall were 2,709.8 per 100,000 individuals and 1,772.4 per 100,000 individuals for both sexes, respectively, in 2013 (Table 10). Among men, the crude and age-standardized prevalence rates for cancer overall were 2,387.1 and 1,683.6 per 100,000 individuals, respectively. Among women the rates for cancer overall were 3,032.6 and 1,944.3 per 100,000 individuals, respectively.
The five most common cancers for men were stomach (CR, 589.0 per 100,000), colorectal (CR, 449.1 per 100,000), prostate (CR, 220.5 per 100,000), thyroid (CR, 194.3 per 100,000), and liver cancer (CR, 163.0 per 100,000). In contrast, thyroid cancer was most common in women (CR, 995.9 per 100,000), followed by breast (CR, 579.3 per 100,000), colorectal (CR, 302.8 per 100,000), stomach (CR, 298.4 per 100,000), and cervix uteri cancer (CR, 181.9 per 100,000).
Analysis of the time period after cancer diagnosis revealed that thyroid cancer (23.2%) was the most prevalent cancer within 2 years after cancer diagnosis, followed by stomach (13.9%) and colorectal cancer (13.3%) (Fig. 6). Thyroid cancer (26.2%) was most prevalent for 2-5 years, followed by stomach (15.4%) and colorectal cancer (14.0%). After 5 years, stomach cancer (18.6%) was the most prevalent cancer, followed by thyroid (18.1%) and colorectal cancer (14.1%).

*The Community of Population-Based Regional Cancer Registries

Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Cancer Registry, Ulsan University Hospital), Heon Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/Chungnam Cancer Registry, Chungnam National University Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Moo-Kyung Oh (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Daegu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/Chonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Yune-Sik Kang (Gyeongnam Cancer Registry, Gyeongsang National University Hospital)

Conflict of interest relevant to this article was not reported.

This work was supported by a research grant from the National Cancer Center (No. 1610200), Republic of Korea. The authors are indebted to Korea Central Cancer Registry (KCCR)-affiliated hospitals, non-KCCR-affiliated hospitals, the National Health Insurance Service and Statistics Korea for data collection.
Fig. 1.
Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2013 in Korea. Age standardization was based on the Segi’s world standard population.
crt-2016-089f1.gif
Fig. 2.
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2013 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2016-089f2.gif
Fig. 3.
Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2013 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2016-089f3.gif
Fig. 4.
Age-specific incidence rates of common cancers for 2013 in Korea. (A) Men. (B) Women.
crt-2016-089f4.gif
Fig. 5.
Trends in relative survival by year of diagnosis from 1999 to 2013. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
crt-2016-089f5.gif
Fig. 6.
Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed between 1999 and 2013.
crt-2016-089f6.gif
Table 1.
Cancer incidence, deaths and prevalence by sex in Korea, 2013
Site/Type New cases
Deaths
Prevalent casesa)
Both sexes Male Female Both sexes Male Female Both sexes Male Female
All sites 225,343 113,744 111,599 75,334 47,079 28,255 1,370,049 603,524 766,525
Lip, oral cavity, and pharynx 3,041 2,181 860 1,078 821 257 18,539 12,476 6,063
Esophagus 2,382 2,186 196 1,448 1,320 128 8,090 7,321 769
Stomach 30,184 20,266 9,918 9,180 5,995 3,185 224,352 148,926 75,426
Colon and rectum 27,618 16,593 11,025 8,199 4,659 3,540 190,094 113,547 76,547
Liver 16,192 12,105 4,087 11,405 8,421 2,984 55,049 41,203 13,846
Gallbladderb) 5,283 2,707 2,576 3,783 1,874 1,909 16,021 8,195 7,826
Pancreas 5,511 2,982 2,529 4,831 2,615 2,216 7,757 4,185 3,572
Larynx 1,196 1,116 80 403 369 34 9,149 8,592 557
Lung 23,177 16,171 7,006 17,177 12,519 4,658 58,653 37,399 21,254
Breast 17,292 61 17,231 2,244 13 2,231 147,012 596 146,416
Cervix uteri 3,633 - 3,633 892 - 892 45,989 - 45,989
Corpus uteri 2,212 - 2,212 248 - 248 17,053 - 17,053
Ovary 2,236 - 2,236 1,038 - 1,038 15,362 - 15,362
Prostate 9,515 9,515 - 1,629 1,629 - 55,756 55,756 -
Testis 254 254 - 19 19 - 2,440 2,440 -
Kidney 4,333 2,992 1,341 937 664 273 29,069 19,621 9,448
Bladder 3,762 3,025 737 1,280 975 305 27,440 22,360 5,080
Brain and CNS 1,813 941 872 1,196 625 571 9,302 4,828 4,474
Thyroid 42,541 8,454 34,087 393 120 273 300,851 49,119 251,732
Hodgkin lymphoma 262 169 93 63 41 22 2,194 1,401 793
Non-Hodgkin lymphoma 4,828 2,668 2,160 1,581 929 652 29,347 15,797 13,550
Multiple myeloma 1,327 694 633 804 437 367 4,325 2,256 2,069
Leukemia 3,011 1,716 1,295 1,593 945 648 16,309 9,002 7,307
Other and ill-defined 13,740 6,948 6,792 3,913 2,089 1,824 79,896 38,504 41,392

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2014. These are patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2013
Site/Type Crude incidence rate per 100,000
Age-standardized incidence rate per 100,000a)
Both sexes Male Female Both sexes Male Female
All sites 445.7 449.9 441.5 290.5 316.5 281.8
Lip, oral cavity, and pharynx 6.0 8.6 3.4 4.0 6.0 2.2
Esophagus 4.7 8.6 0.8 2.9 6.0 0.4
Stomach 59.7 80.2 39.2 37.4 55.3 22.4
Colon and rectum 54.6 65.6 43.6 34.0 45.6 24.4
Liver 32.0 47.9 16.2 20.2 32.8 9.0
Gallbladderb) 10.4 10.7 10.2 6.1 7.4 5.0
Pancreas 10.9 11.8 10.0 6.6 8.2 5.2
Larynx 2.4 4.4 0.3 1.5 3.1 0.2
Lung 45.8 64.0 27.7 27.4 44.2 14.9
Breast 34.2 0.2 68.2 23.0 0.2 45.7
Cervix uteri 7.2 - 14.4 4.8 - 9.5
Corpus uteri 4.4 - 8.8 2.9 - 5.8
Ovary 4.4 - 8.8 3.1 - 6.0
Prostate 18.8 37.6 - 11.4 26.2 -
Testis 0.5 1.0 - 0.5 1.0 -
Kidney 8.6 11.8 5.3 5.7 8.3 3.4
Bladder 7.4 12.0 2.9 4.4 8.3 1.4
Brain and CNS 3.6 3.7 3.4 2.9 3.2 2.7
Thyroid 84.1 33.4 134.9 60.1 24.0 96.6
Hodgkin lymphoma 0.5 0.7 0.4 0.4 0.6 0.3
Non-Hodgkin lymphoma 9.5 10.6 8.5 6.7 8.0 5.6
Multiple myeloma 2.6 2.7 2.5 1.6 1.9 1.4
Leukemia 6.0 6.8 5.1 5.0 6.0 4.2
Other and ill-defined 27.2 27.5 26.9 17.8 20.5 15.6

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3.
The top 10 leading causes of death in Korea, 2013
Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
All causes 266,257 100.0 309.4
1 Cancer 75,334 28.3 87.9
2 Cerebrovascular disease 25,447 9.6 27.0
3 Heart disease 25,365 9.5 27.9
4 Intentional self-harm (suicide) 14,427 5.4 20.3
5 Diabetes mellitus 10,888 4.1 11.6
6 Pneumonia 10,809 4.1 11.2
7 Chronic lower respiratory diseases 7,074 2.7 7.3
8 Disease of liver 6,665 2.5 8.3
9 Transport accidents 6,028 2.3 8.7
10 Hypertensive diseases 4,732 1.8 4.9
Others 79,488 29.9 94.4

Source: Mortality Data, 2013, Statistics Korea [8].

a) Age-adjusted using the world standard population.

Table 4.
Crude and age-standardized cancer mortality rates by sex in Korea, 2013
Site/Type Crude mortality rate per 100,000
Age-standardized mortality rate per 100,000a)
Both sexes Male Female Both sexes Male Female
All sites 149.0 186.2 111.8 87.9 130.1 57.5
Lip, oral cavity, and pharynx 2.1 3.2 1.0 1.3 2.3 0.5
Esophagus 2.9 5.2 0.5 1.7 3.6 0.3
Stomach 18.2 23.7 12.6 10.5 16.4 6.1
Colon and rectum 16.2 18.4 14.0 9.3 12.9 6.7
Liver 22.6 33.3 11.8 13.8 22.9 6.1
Gallbladderb) 7.5 7.4 7.6 4.2 5.2 3.5
Pancreas 9.6 10.3 8.8 5.6 7.2 4.4
Larynx 0.8 1.5 0.1 0.4 1.0 0.1
Lung 34.0 49.5 18.4 19.3 34.0 8.8
Breast 4.4 0.1 8.8 2.9 0.0 5.6
Cervix uteri 1.8 - 3.5 1.1 - 1.9
Corpus uteri 0.5 - 1.0 0.3 - 0.6
Ovary 2.1 - 4.1 1.3 - 2.4
Prostate 3.2 6.4 - 1.7 4.8 -
Testis 0.0 0.1 - 0.0 0.1 -
Kidney 1.9 2.6 1.1 1.1 1.8 0.5
Bladder 2.5 3.9 1.2 1.4 2.8 0.5
Brain and CNS 2.4 2.5 2.3 1.7 2.0 1.5
Thyroid 0.8 0.5 1.1 0.4 0.3 0.5
Hodgkin lymphoma 0.1 0.2 0.1 0.1 0.1 0.1
Non-Hodgkin lymphoma 3.1 3.7 2.6 1.9 2.6 1.3
Multiple myeloma 1.6 1.7 1.5 0.9 1.2 0.8
Leukemia 3.2 3.7 2.6 2.2 2.9 1.6
Other and ill-defined 7.7 8.3 7.2 4.7 6.0 3.8

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5.
Trends in cancer incidence rates for both sexes from 1999 to 2013 in Korea
Site/Type Year
APC
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
All sites 210.5 205.1 216.7 220.1 227.9 235.1 247.9 252.2 263.5 276.1 286.9 293.5 303.8 301.7 290.5 3.1a)
Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 4.0 4.1 4.0 4.0 0.4
Esophagus 4.1 3.7 3.9 3.8 3.6 3.6 3.5 3.4 3.3 3.3 3.1 3.1 3.0 3.0 2.9 –2.2a)
Stomach 43.6 42.3 44.0 43.6 43.3 41.2 44.4 42.8 41.8 42.6 43.4 42.5 42.8 40.1 37.4 -0.6
Colon and rectum 20.4 21.0 22.9 24.7 26.9 28.6 31.0 32.5 33.8 34.9 36.9 36.9 38.3 37.7 34.0 4.6a)
Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.6 24.4 24.1 23.5 22.8 22.5 21.2 20.2 –2.0a)
Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.8 6.6 6.4 6.3 6.1 –0.3
Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.4 6.7 6.8 6.6 1.5a)
Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.7 1.7 1.6 1.5 1.4 1.5 –3.5a)
Lung 28.5 27.7 28.3 28.5 27.9 28.8 29.0 28.7 28.4 28.2 28.3 28.6 28.7 27.7 27.4 –0.1
Breast 10.7 10.8 12.7 13.9 14.3 15.0 16.3 17.0 18.1 18.9 19.7 20.7 22.3 22.7 23.0 5.8a)
Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.9 6.5 6.4 5.7 5.9 5.5 5.6 5.2 4.9 4.8 –4.1a)
Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.2 2.4 2.6 2.6 2.7 2.7 2.9 5.6a)
Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.1 2.9 2.8 3.0 3.0 3.1 3.1 1.4a)
Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.8 10.6 11.0 11.9 11.7 11.4 12.0a)
Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 4.6a)
Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.1 5.2 5.3 5.6 5.6 5.7 5.5a)
Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.6 4.7 4.7 4.4 4.4 –0.5
Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.1 3.0 3.1 2.7 2.9 2.9 0.4
Thyroid 6.3 6.1 7.9 9.5 12.8 17.3 20.7 25.5 32.9 41.4 48.2 53.7 59.2 63.2 60.1 20.8a)
Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.4 4.7a)
Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 5.0 5.3 5.3 5.5 5.6 5.7 6.2 6.2 6.6 6.7 6.7 3.5a)
Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 1.4 1.6 1.6 3.6a)
Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.9 5.0 5.1 5.0 5.2 5.0 5.0 0.9a)
Other and ill-defined 14.3 13.5 13.9 13.5 15.2 15.3 16.2 16.2 17.3 17.1 17.2 17.6 18.3 17.9 17.8 2.3a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6.
Trends in cancer incidence rates in men from 1999 to 2013 in Korea
Site/Type Year
APC
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
All sites 285.0 276.7 288.3 290.0 295.1 299.6 311.4 310.3 317.1 324.2 330.9 332.0 337.2 329.1 316.5 1.3a)
Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.2 6.3 6.5 6.1 6.1 6.4 6.2 6.0 –0.2
Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 7.0 7.0 6.6 6.5 6.3 6.1 6.0 –2.6a)
Stomach 66.2 65.0 67.2 66.6 66.0 62.3 66.9 65.3 63.1 64.5 65.0 63.4 63.8 59.6 55.3 –0.8a)
Colon and rectum 26.2 27.2 29.6 32.9 35.3 38.0 41.2 43.3 45.3 47.0 50.0 50.1 52.0 50.4 45.6 5.0a)
Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.3 39.8 39.5 38.2 36.9 36.1 34.5 32.8 –2.2a)
Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.1 8.2 7.7 7.6 7.4 –0.4
Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 8.1 8.6 8.5 8.2 0.7a)
Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.8 3.8 3.5 3.6 3.4 3.2 3.0 3.1 –3.6a)
Lung 51.4 49.8 51.1 51.0 50.0 50.8 50.9 49.2 48.8 47.7 47.5 47.5 46.7 44.7 44.2 –1.0a)
Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 –1.4
Prostate 8.4 7.2 9.5 10.1 12.5 15.2 15.8 18.0 20.9 23.5 25.3 26.1 27.7 27.3 26.2 10.7a)
Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 4.5a)
Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.1 7.5 7.6 8.0 8.1 8.3 8.3 5.2a)
Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.5 9.2 8.7 8.9 8.9 8.3 8.3 –0.7a)
Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.2 3.4 3.4 3.5 3.5 3.0 3.3 3.2 0.5
Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.6 18.6 20.4 23.3 24.0 22.7a)
Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 3.9a)
Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.5 7.4 7.7 7.9 8.0 2.7a)
Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.8 1.8 2.0 1.9 3.3a)
Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 6.1 5.9 6.0 1.0a)
Other and ill-defined 17.9 16.5 16.8 16.5 18.5 18.3 19.3 18.9 20.4 19.8 20.0 19.9 20.9 20.3 20.5 1.6a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7.
Trends in cancer incidence rates in women from 1999 to 2013 in Korea
Site/Type Year
APCa)
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
All sites 161.1 157.4 169.0 174.6 184.6 193.9 208.1 216.7 232.5 249.9 263.9 275.5 290.3 292.9 281.8 5.1a)
Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.2 2.1 2.0 2.2 1.3
Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 0.4 0.5 0.4 –2.2a)
Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.1 24.8 25.1 25.8 25.4 25.3 23.7 22.4 –0.7a)
Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 23.0 24.1 24.6 25.2 26.3 26.1 26.8 27.1 24.4 3.7a)
Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.7 10.6 10.4 10.5 9.6 9.0 –1.8a)
Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 5.5 5.3 5.0 –0.5
Pancreas 4.0 4.0 4.0 4.2 4.4 4.5 4.7 4.7 4.8 4.9 4.9 5.0 5.1 5.4 5.2 2.2a)
Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 –7.0a)
Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 14.0 14.2 14.2 14.8 15.4 15.1 14.9 1.7a)
Breast 20.9 20.9 24.7 27.2 27.9 29.4 32.1 33.3 35.7 37.3 38.8 40.8 44.1 44.9 45.7 5.9a)
Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.2 12.4 12.2 11.1 11.5 10.7 10.9 10.2 9.6 9.5 –3.9a)
Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.1 5.3 5.4 5.8 5.8a)
Ovary 5.0 4.8 4.8 5.0 5.2 5.2 5.5 5.4 5.9 5.6 5.4 5.9 5.8 6.1 6.0 1.7a)
Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 3.4 3.2 3.4 5.4a)
Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 1.5 1.4 1.4 –1.1a)
Brain and CNS 2.6 2.5 2.5 2.4 2.6 2.6 2.8 2.7 2.8 2.7 2.6 2.7 2.5 2.4 2.7 0.2
Thyroid 10.4 10.1 13.2 16.2 21.9 29.6 35.4 43.4 55.7 69.6 80.8 89.0 98.3 103.5 96.6 20.6a)
Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 5.7a)
Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 4.0 4.1 4.4 4.4 4.4 4.8 5.2 5.2 5.6 5.7 5.6 4.4a)
Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 1.1 1.4 1.4 4.1a)
Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.3 4.1 4.5 4.1 4.2 0.7a)
Other and ill-defined 11.8 11.5 11.8 11.5 12.9 13.2 13.9 14.2 14.9 15.0 14.9 15.8 16.2 15.9 15.6 2.7a)

APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 8.
The five common sites of cancer incidence by age group and sex in Korea, 2013
Rank Age (yr)
0-14 15-34 35-64 ≥ 65
Male
 1 Leukemia (4.3) Thyroid (17.7) Stomach (88.3) Lung (449.4)
 2 Non-Hodgkin lymphoma (2.4) Leukemia (3.5) Colon and rectum (69.5) Stomach (396.3)
 3 Brain and CNS (2.0) Colon and rectum (3.2) Liver (62.4) Colon and rectum (333.4)
 4 Liver (0.4) Non-Hodgkin lymphoma (3.0) Thyroid (54.6) Prostate (289.3)
 5 Testis (0.4) Stomach (2.3) Lung (42.4) Liver (192.1)
Female
 1 Leukemia (3.4) Thyroid (71.7) Thyroid (228.2) Colon and rectum (176.5)
 2 Brain and CNS (1.9) Breast (10.6) Breast (123.9) Stomach (149.3)
 3 Non-Hodgkin lymphoma (1.1) Cervix uteri (5.5) Colon and rectum (40.8) Lung (126.6)
 4 Thyroid (0.6) Stomach (3.4) Stomach (38.8) Thyroid (92.7)
 5 Ovary (0.6) Ovary (3.1) Lung (21.7) Liver (72.5)

CNS, central nervous system.

Table 9.
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2013 in Korea
Site/Type Both sexes
Male
Female
1993-1995 1996-2000 2001-2005 2008-2013 Changea) 1993-1995 1996-2000 2001-2005 2008-2013 Changea) 1993-1995 1996-2000 2001-2005 2009-2013 Changea)
All sites 41.2 44.0 53.8 69.4 28.2 31.7 35.3 45.3 61.0 29.3 53.4 55.3 64.0 77.7 24.3
Lip, oral cavity, and pharynx 41.1 46.7 54.2 63.1 22.0 35.8 41.1 49.4 59.3 23.5 58.1 63.8 67.7 73.0 14.9
Esophagus 12.7 15.2 21.2 33.4 20.7 11.8 14.3 20.5 33.1 21.3 23.7 24.2 29.6 36.1 12.4
Stomach 42.8 46.6 57.7 73.1 30.3 43.0 46.9 58.4 73.9 30.9 42.6 46.0 56.4 71.5 28.9
Colon and rectum 54.8 58.0 66.6 75.6 20.8 55.3 59.0 68.5 77.5 22.2 54.2 56.8 64.2 72.6 18.4
Liver 10.7 13.2 20.2 31.4 20.7 9.9 12.9 20.2 31.6 21.7 13.6 14.2 20.4 30.8 17.2
Gallbladderb) 17.3 19.7 22.8 29.0 11.7 16.6 20.3 23.3 30.2 13.6 18.0 19.1 22.3 27.9 9.9
Pancreas 9.4 7.6 8.2 9.4 - 8.8 7.3 8.2 9.2 0.4 10.1 8.1 8.1 9.7 –0.4
Larynx 59.7 62.3 66.2 73.1 13.4 60.2 62.8 66.8 73.5 13.3 55.4 57.8 58.2 66.9 11.5
Lung 11.3 12.7 16.2 23.5 12.2 10.4 11.6 15.0 20.5 10.1 14.2 16.2 19.7 30.6 16.4
Breast 77.9 83.2 88.5 91.5 13.6 75.1 85.6 87.0 91.6 16.5 78.0 83.2 88.5 91.5 13.5
Cervix uteri 77.5 80.0 81.3 80.1 2.6 - - - - - 77.5 80.0 81.3 80.1 2.6
Corpus uteri 81.5 81.8 84.6 87.9 6.4 - - - - - 81.5 81.8 84.6 87.9 6.4
Ovary 58.7 58.9 61.4 62.0 3.3 - - - - - 58.7 58.9 61.4 62.0 3.3
Prostate 55.9 67.2 80.2 92.5 36.6 55.9 67.2 80.2 92.5 36.6 - - - - -
Testis 85.4 90.4 90.6 94.9 9.5 85.4 90.4 90.6 94.9 9.5 - - - - -
Kidney 62.0 66.1 73.4 80.8 18.8 60.8 64.4 72.8 80.5 19.7 64.5 69.7 74.5 81.6 17.1
Bladder 69.1 73.1 75.6 75.3 6.2 70.0 74.8 77.4 77.4 7.4 65.5 66.3 68.5 67.0 1.5
Brain and CNS 38.5 39.0 40.7 41.8 3.3 37.2 37.5 40.1 40.1 2.9 40.2 40.7 41.4 43.9 3.7
Thyroid 94.2 94.9 98.3 100.2 6.0 87.2 89.5 95.8 100.6 13.4 95.4 95.9 98.7 100.1 4.7
Hodgkin lymphoma 68.0 71.2 76.6 78.2 10.2 67.6 68.1 74.6 78.6 11.0 68.6 77.4 80.7 77.5 8.9
Non-Hodgkin lymphoma 46.6 50.8 60.0 68.4 21.8 45.3 48.9 58.1 66.6 21.3 48.7 53.5 62.4 70.5 21.8
Multiple myeloma 22.1 19.8 29.3 38.9 16.8 21.1 17.8 29.6 37.6 16.5 23.3 22.1 29.0 40.5 17.2
Leukemia 26.5 33.3 41.8 49.7 23.2 26.2 32.3 41.7 49.7 23.5 26.8 34.6 42.0 49.6 22.8
Other and ill-defined 42.1 45.9 55.9 68.1 26.0 37.4 42.4 52.2 64.6 27.2 47.4 50.0 60.0 71.7 24.3

CNS, central nervous system.

a) Percentage change in 5-year relative survival from 1993 to 1995 and 2009 to 2013,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 10.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2014 in Korea
Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Male Female Both sexes Male Female
All sites 2,709.8 2,387.1 3,032.6 1,772.4 1,683.6 1,944.3
Lip, oral cavity, and pharynx 36.7 49.3 24.0 24.3 34.7 15.3
Esophagus 16.0 29.0 3.0 9.9 20.0 1.7
Stomach 443.7 589.0 298.4 276.0 405.3 169.9
Colon and rectum 376.0 449.1 302.8 232.6 311.2 169.7
Liver 108.9 163.0 54.8 71.1 113.2 33.2
Gallbladderc) 31.7 32.4 31.0 19.0 22.3 16.5
Pancreas 15.3 16.6 14.1 9.7 11.6 8.2
Larynx 18.1 34.0 2.2 11.2 23.6 1.2
Lung 116.0 147.9 84.1 71.8 102.7 48.1
Breast 290.8 2.4 579.3 191.6 1.6 376.3
Cervix uteri 91.0 - 181.9 59.1 - 115.0
Corpus uteri 33.7 - 67.5 22.6 - 44.2
Ovary 30.4 - 60.8 21.6 - 42.7
Prostate 110.3 220.5 - 63.1 152.1 -
Testis 4.8 9.7 - 4.4 8.6 -
Kidney 57.5 77.6 37.4 38.2 54.5 23.9
Bladder 54.3 88.4 20.1 32.2 61.4 10.1
Brain and CNS 18.4 19.1 17.7 15.9 16.9 14.8
Thyroid 595.0 194.3 995.9 409.6 135.5 681.9
Hodgkin lymphoma 4.3 5.5 3.1 3.6 4.6 2.7
Non-Hodgkin lymphoma 58.0 62.5 53.6 41.9 47.7 36.7
Multiple myeloma 8.6 8.9 8.2 5.4 6.1 4.8
Leukemia 32.3 35.6 28.9 30.6 34.2 27.0
Other and ill-defined 158.0 152.3 163.8 107.2 115.8 100.2

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using the world standard population,

c) Includes the gallbladder and other/unspecified parts of the biliary tract.

  • 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer; 2013. [cited 2016 Jan 28]. Available from: http://globocan.iarc.fr
  • 2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71. ArticlePubMed
  • 3. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015;47:127–41. ArticlePubMedPMCPDF
  • 4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee DH, et al. Prediction of cancer incidence and mortality in Korea, 2015. Cancer Res Treat. 2015;47:142–8. ArticlePubMedPMCPDF
  • 5. Lee KS, Chang HS, Lee SM, Park EC. Economic burden of cancer in Korea during 2000-2010. Cancer Res Treat. 2015;47:387–98. ArticlePubMedPMCPDF
  • 6. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001; first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMCPDF
  • 7. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 8. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2015. [cited 2015 Jan 28]. Available from: http://kosis.kr
  • 9. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
  • 10. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
  • 11. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER cancer statistics review, 1975-2012 [Internet]. Bethesda, MD: National Cancer Institute; 2013. [cited 2015 Jan 28]. Available from: http://seer.cancer.gov/csr/1975_2012/
  • 12. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 13. Day NE. Cumulative rates and cumulative risk. In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, editors. Cancer incidence in five continents. Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer; 787. p. 1011–9.
  • 14. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note, No. 10. Bethesda, MD: National Cancer Institute; 1959.
  • 15. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2016 Jan 14]. Available from: http//www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place o
      Takuji Gotoda, Hideki Ishikawa, Chika Kusano, Sho Suzuki, Hirohide Ohnishi, Kentaro Sugano, Yutaka Matsuyama
      Gastric Cancer.2024; 27(1): 36.     CrossRef
    • Cancer screening programs in South-east Asia and Western Pacific
      Hwee-Lin Wee, Karen Canfell, Han-Mo Chiu, Kui Son Choi, Brian Cox, Nirmala Bhoo-Pathy, Kate T Simms, Chisato Hamashima, Qianyu Shen, Brandon Chua, Niyomsri Siwaporn, Esther Toes-Zoutendijk
      BMC Health Services Research.2024;[Epub]     CrossRef
    • Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
      Soon‐Hyo Kwon, Sangmin Choi, Joung Soo Kim, Sang Seok Kim, Mihn‐Sook Jue, Soo Hong Seo, Jihye Park, Mi Ryung Roh, Je‐Ho Mun, Jun Young Kim, Jee Woong Choi, Ji Won Byun, Sanghyun Park, Min Sung Kim, Seok‐Jong Lee
      The Journal of Dermatology.2024; 51(4): 532.     CrossRef
    • Geraniol and citral: recent developments in their anticancer credentials opening new vistas in complementary cancer therapy
      Gauri Srivastava, Esha Mukherjee, Ruchika Mittal, Deepak Ganjewala
      Zeitschrift für Naturforschung C.2024; 79(7-8): 163.     CrossRef
    • Gastric cancer detection rates using GI endoscopy with serologic risk stratification: a randomized controlled trial
      Chika Kusano, Takuji Gotoda, Hideki Ishikawa, Sho Suzuki, Hisatomo Ikehara, Yutaka Matsuyama
      Gastrointestinal Endoscopy.2024; 100(1): 55.     CrossRef
    • Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort
      Juhun Lee, Dong Ja Kim, Hyun Jung Lee
      Scientific Reports.2024;[Epub]     CrossRef
    • Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea
      Kyeongmin Kwak, Seung-sik Hwang
      Cancer Research and Treatment.2024; 56(3): 898.     CrossRef
    • Living lab modelling as a pilot study assessing the potential psychological health benefits of forest environment for cancer survivors
      Mi-Kyung Kim, Hyo Jin Park, Kyung Ju Lee
      Obstetrics & Gynecology Science.2024; 67(4): 404.     CrossRef
    • Surgical and Survival Outcomes of Operable Gastric Cancer—Experience from a Tertiary Care Center in South India
      D. Suresh Kumar, S. Navin Noushad, M. P. Viswanathan, Vishnu Deepthi S.
      Indian Journal of Surgical Oncology.2023; 14(1): 48.     CrossRef
    • Overview of Chemotherapy for Gastric Cancer
      Yasushi Sato, Koichi Okamoto, Yoshifumi Kida, Yasuhiro Mitsui, Yutaka Kawano, Masahiro Sogabe, Hiroshi Miyamoto, Tetsuji Takayama
      Journal of Clinical Medicine.2023; 12(4): 1336.     CrossRef
    • Underuse of Gastric Cancer Screening Services among Koreans with Type 2 Diabetes
      Kumban Walter Chuck, Seri Hong, Yunhwan Lee
      Healthcare.2023; 11(7): 927.     CrossRef
    • Linking dysbiosis to precancerous stomach through inflammation: Deeper than and beyond imaging
      Catarina Lopes, Tatiana C. Almeida, Pedro Pimentel-Nunes, Mário Dinis-Ribeiro, Carina Pereira
      Frontiers in Immunology.2023;[Epub]     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Do Concurrent Multiple Infections with High-Risk HPVs Carry a More Malignant Potential than a Single Infection in the Uterine Cervix?
      Juhun Lee, Hyun Jung Lee
      Journal of Clinical Medicine.2023; 12(19): 6155.     CrossRef
    • An Investigation into Cell-Free DNA in Different Common Cancers
      Samira Nafar, Kamran Hosseini, Negin Shokrgozar, Amir Yousef Farahmandi, Vahab Alamdari-Palangi, Ali Saber Sichani, Jafar Fallahi
      Molecular Biotechnology.2023;[Epub]     CrossRef
    • Comparative Analysis of Driver Mutations and Transcriptomes in Papillary Thyroid Cancer by Region of Residence in South Korea
      Jandee Lee, Seonhyang Jeong, Hwa Young Lee, Sunmi Park, Meesson Jeong, Young Suk Jo
      Endocrinology and Metabolism.2023; 38(6): 720.     CrossRef
    • Mobile web‐based self‐management program for breast cancer patients with chemotherapy‐induced amenorrhoea: A quasi‐experimental study
      Jin‐Hee Park, Yong Sik Jung, Ji Young Kim, Sun Hyoung Bae
      Nursing Open.2022; 9(1): 655.     CrossRef
    • Structural and functional brain alterations associated with cancer‐associated cognitive decline in gastric cancer patients: A preliminary longitudinal neuroimaging study
      Jaeun Ahn, DeokJong Lee, Young‐Chul Jung, Kyung Ran Kim
      Brain and Behavior.2022;[Epub]     CrossRef
    • Trends in the incidence of thyroid cancer in Incheon Province, South Korea, from 2004 to 2013: A representative sample study from Incheon cancer registry
      Jeongshim Lee, Hyun Young Lee, Woo Chul Kim
      Asia-Pacific Journal of Clinical Oncology.2022;[Epub]     CrossRef
    • Impact of overweight and obesity on the risk of hepatocellular carcinoma: a prospective cohort study in 14.3 million Koreans
      Baek Gyu Jun, Moonho Kim, Hwang Sik Shin, Jee-Jeon Yi, Sang-Wook Yi
      British Journal of Cancer.2022; 127(1): 109.     CrossRef
    • Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults
      In Rae Cho, Sang-Wook Yi, Ja Sung Choi, Jee-Jeon Yi
      Cancers.2022; 14(7): 1709.     CrossRef
    • An empirical review on the risk factors, therapeutic strategies and materials at nanoscale for the treatment of oral malignancies
      Parveez Ahamed Abdul Azees, Suganthy Natarajan, Bennett T. Amaechi, Nooruddin Thajuddin, Vinay B. Raghavendra, Kathirvel Brindhadevi, Arivalagan Pugazhendhi, Tran Nhat Phuong
      Process Biochemistry.2022; 118: 283.     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • Clinical assessment of T2 papillary thyroid carcinoma: a retrospective study conducted at a single tertiary institution
      Hyesung Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
      Scientific Reports.2022;[Epub]     CrossRef
    • Incidence of Cancer and Asbestos-Related Diseases among Residents Living near Abandoned Asbestos Mines in South Korea: A Retrospective Cohort Study Using National Health Insurance Database
      Kyeongmin Kwak, Kyung Ehi Zoh, Domyung Paek
      International Journal of Environmental Research and Public Health.2021; 18(3): 875.     CrossRef
    • Impact of prior cancer history on survival of patients with gastric cancer
      Li Wen, Kun Yu, Hongjiang Lu, Guansheng Zhong
      European Journal of Surgical Oncology.2021; 47(9): 2286.     CrossRef
    • Effect of prior cancer on survival outcomes for patients with advanced prostate cancer
      Yechen Wu, Xi Chen, Duocheng Qian, Wei Wang, Yiping Zhang, Jinxin Hu, Jun Zhu, Qiang Wu, Tinghu Cao
      BMC Urology.2021;[Epub]     CrossRef
    • Apoptotic Effects of Anthocyanins from Vitis coignetiae Pulliat Are Enhanced by Augmented Enhancer of the Rudimentary Homolog (ERH) in Human Gastric Carcinoma MKN28 Cells
      Cheol Park, Won Sup Lee, Se-Il Go, Sang-Ho Jeong, Jiyun Yoo, Hee-Jae Cha, Young-Joon Lee, Heui-Soo Kim, Sun-Hee Leem, Hye Jung Kim, Gon Sup Kim, Soon-Chan Hong, Yung Hyun Choi
      International Journal of Molecular Sciences.2021; 22(6): 3030.     CrossRef
    • Prior to Breast MRI Guidelines in Korea, Where Were We?
      Cheong Hoon Hwang, Miribi Rho, Minah Lee, Ga Ram Kim, Vivian Youngjean Park, Jung Hyun Yoon, Min Jung Kim
      Investigative Magnetic Resonance Imaging.2021; 25(1): 35.     CrossRef
    • An Adaptive Machine Learning System for predicting recurrence of child maltreatment: A routine activity theory perspective
      Yuzhang Han, Minoo Modaresnezhad, Hamid Nemati
      Knowledge-Based Systems.2021; 227: 107164.     CrossRef
    • Transpyloric optic navigation of tumor using a laparoscope during totally laparoscopic distal gastrectomy for gastric cancer
      Sola Lee, Ho Goon Kim, Dong Yeon Kang, Dong Yi Kim, Seong Yeob Ryu
      Journal of Minimally Invasive Surgery.2021; 24(2): 76.     CrossRef
    • Recurrence of Cancer-associated Venous Thromboembolism between 2009 and 2013: A Nationwide Korean Study
      Hun-Gyu Hwang, Ju Hyun Lee, Junshik Hong, Sang-A Kim, Yang-Ki Kim, Myung Shin Kim, Soo-Mee Bang
      Clinical & Experimental Thrombosis and Hemostasis.2021; 7(1): 14.     CrossRef
    • Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
      Hong Jun Kim, Suk-young Lee, Dae Sik Kim, Eun Joo Kang, Jung Sun Kim, Yoon Ji Choi, Sang Cheul Oh, Jae Hong Seo, Jun Suk Kim
      The Korean Journal of Internal Medicine.2020; 35(1): 171.     CrossRef
    • Effects of a web-based expert support self-management program (WEST) for women with breast cancer: A randomized controlled trial
      Hye-Jin Kim, Hee-Seung Kim
      Journal of Telemedicine and Telecare.2020; 26(7-8): 433.     CrossRef
    • Survival Rate of Prostate Cancer in Asian Countries: A Systematic Review and Meta-Analysis
      Soheil Hassanipour, Hamed Delam, Morteza Arab-Zozani, Elham Abdzadeh, Seyyed Ali Hosseini, Hossein-Ali Nikbakht, Mahdi Malakoutikhah, Mohammad Taghi Ashoobi, Mohammad Fathalipour, Hamid Salehiniya, Shirin Riahi
      Annals of Global Health.2020; 86(1): 2.     CrossRef
    • Trends in Influenza Vaccination Coverage Rates among Korean Cancer Survivors: Analysis of the Korea National Health and Nutrition Examination Survey III–VI
      Ye-Seul Kim, Jae-woo Lee, Hee-Taik Kang, Yonghwan Kim, Hyo-Sun You
      Korean Journal of Family Medicine.2020; 41(1): 45.     CrossRef
    • Metabolic comorbidities and medical institution utilization among breast cancer survivors: a national population-based study
      Jaesung Heo, Mison Chun, Young-Taek Oh, O Kyu Noh, Logyoung Kim
      The Korean Journal of Internal Medicine.2020; 35(2): 421.     CrossRef
    • Suicide risk after cancer diagnosis among older adults: A nationwide retrospective cohort study
      Jae Woo Choi, Eun-Cheol Park
      Journal of Geriatric Oncology.2020; 11(5): 814.     CrossRef
    • The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
      Arash Etemadi, Saeid Safiri, Sadaf G Sepanlou, Kevin Ikuta, Catherine Bisignano, Ramin Shakeri, Mohammad Amani, Christina Fitzmaurice, Molly Nixon, Nooshin Abbasi, Hassan Abolhassani, Shailesh M Advani, Mohsen Afarideh, Tomi Akinyemiju, Tahiya Alam, Mahta
      The Lancet Gastroenterology & Hepatology.2020; 5(1): 42.     CrossRef
    • Characterization of Metabolic Syndrome Risk Factors and Health-Related Behaviors in Korean Patients With Breast Cancer by Abdominal Obesity Status
      Hye-Jin KIM, Hee-Seung KIM, Hye-Ryoung KIM, Yang-Sook YOO, Byung Joo SONG
      Journal of Nursing Research.2020; 28(2): e74.     CrossRef
    • Citral Induced Apoptosis through Modulation of Key Genes Involved in Fatty Acid Biosynthesis in Human Prostate Cancer Cells: In Silico and In Vitro Study
      Sri Renukadevi Balusamy, Haribalan Perumalsamy, Karpagam Veerappan, Md. Amdadul Huq, S. Rajeshkumar, T. Lakshmi, Yeon Ju Kim
      BioMed Research International.2020; 2020: 1.     CrossRef
    • Thyroid isthmus agenesis and its clinical significance in a large-scale multidetector CT-based study
      Seung Kwan Kim, Hyung Suk Seo, Young Hen Lee, Gil Soo Son, Sang-il Suh
      Clinical Imaging.2020; 66: 106.     CrossRef
    • Age-Specific Breast Density Changes in Taiwanese Women: A Cross-Sectional Study
      Yu-San Liao, Jia-Yu Zhang, Yuan-Chi Hsu, Min-Xuan Hong, Li-Wen Lee
      International Journal of Environmental Research and Public Health.2020; 17(9): 3186.     CrossRef
    • Association between the National Cancer Screening Programme (NSCP) for gastric cancer and oesophageal cancer mortality
      Jie-Hyun Kim, Kyung-Do Han, Jung Kuk Lee, Hyun-Soo Kim, Jae Myung Cha, Sohee Park, Joo Sung Kim, Won Ho Kim
      British Journal of Cancer.2020; 123(3): 480.     CrossRef
    • Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system
      Kwangsoon Kim, Jin Kyong Kim, Cho Rok Lee, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung
      Therapeutic Advances in Endocrinology and Metabolism.2020;[Epub]     CrossRef
    • Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30‐Year Experience at a Single Institution
      Kwangsoon Kim, Cho Rok Lee, Sang‐Wook Kang, Jandee Lee, Jong Ju Jeong, Kee‐Hyun Nam, Woong Youn Chung
      World Journal of Surgery.2020; 44(10): 3383.     CrossRef
    • The Combined Impact of Chronic Kidney Disease and Diabetes on the Risk of Colorectal Cancer Depends on Sex: A Nationwide Population-Based Study
      Hyung Jung Oh, Hye Ah Lee, Chang Mo Moon, Dong-Ryeol Ryu
      Yonsei Medical Journal.2020; 61(6): 506.     CrossRef
    • Nationwide Trends in the Incidence and Survival of Eyelid Skin Cancers in Korea
      Su-Kyung Jung, Jiwon Lim, Suk-Woo Yang, Donghyun Jee, Young-Joo Won
      Ophthalmic Epidemiology.2020; 27(6): 438.     CrossRef
    • The Clinical Impact of Body Mass Index on Breast Cancer in Korea: A Nationwide Population-Based Cohort Study
      Jae Hwan Jeong, Hak Min Lee, Hai Young Son, Ilkyun Lee
      Journal of Breast Disease.2020; 8(1): 51.     CrossRef
    • Risk of malignancy in Korean patients with primary Sjögren's syndrome
      Juyeon Kang, Hyoungyoung Kim, Jinwook Kim, Seongmi Choi, Sun‐Young Jung, Eun Jin Jang, Soo‐Kyung Cho, Yoon‐Kyoung Sung
      International Journal of Rheumatic Diseases.2020; 23(9): 1240.     CrossRef
    • Fasting Plasma Glucose Variability and Gastric Cancer Risk in Individuals Without Diabetes Mellitus: A Nationwide Population-Based Cohort Study
      So-hyeon Hong, Eunjin Noh, Jinsil Kim, Soon Young Hwang, Jun A. Kim, You-Bin Lee, Eun Roh, Kyung Mook Choi, Sei Hyun Baik, Geum Joon Cho, Hye Jin Yoo
      Clinical and Translational Gastroenterology.2020; 11(9): e00221.     CrossRef
    • Factors Affecting Onset and Persistence of Metabolic Syndrome in Korean Breast Cancer Survivors: A Prospective Study
      Suyoun Maeng, Jungok Yu
      International Journal of Environmental Research and Public Health.2020; 17(18): 6814.     CrossRef
    • Clinical Characteristics and Prognostic Factors of Lung Cancer in Korea: A Pilot Study of Data from the Korean Nationwide Lung Cancer Registry
      Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Young-Chul Kim, Jung-Eun Kim, Boram Lee, Young-Joo Won, Chang-Min Choi
      Tuberculosis and Respiratory Diseases.2019; 82(2): 118.     CrossRef
    • Could Peer Support Programs Be a Good Resource for Managing the Unmet Needs of Cancer Patients?
      Hwa Yeon Park, Mi Jin Kim, Ju Young Kim, Sarah Kim, Ji Young Choi, Jeong Hyun Kim, Hee Yeong Jeong
      Journal of Cancer Education.2019; 34(5): 950.     CrossRef
    • Presentation and Survival of Gastric Cancer Patients at an Urban Academic Safety-Net Hospital
      Ryan Morgan, Michael Cassidy, Susanna W.L. DeGeus, Jennifer Tseng, David McAneny, Teviah Sachs
      Journal of Gastrointestinal Surgery.2019; 23(2): 239.     CrossRef
    • Regional Differences in Colorectal Cancer Mortality Between 2000 and 2013 in Republic of Korea
      Hyeong Taek Woo, Jin Ah Sim, Jonghoon Mo, Young Ho Yun, Aesun Shin
      Journal of Epidemiology.2019; 29(10): 399.     CrossRef
    • Effect of gastrectomy on blood pressure in early gastric cancer survivors with hypertension
      Hak Jin Kim, Eun Jeong Cho, Mi Hyang Kwak, Bang Wool Eom, Hong Man Yoon, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Keun Won Ryu, Young-Woo Kim, Il Ju Choi
      Supportive Care in Cancer.2019; 27(6): 2237.     CrossRef
    • Increased prevalence of metabolic syndrome in adult cancer survivors: Asian first report in community setting
      Minkyung Kim, In-Hoo Kim, Min Kyung Lim, Yeol Kim, Boyoung Park
      Cancer Epidemiology.2019; 58: 130.     CrossRef
    • Prediagnosis obesity and secondary primary cancer risk in female cancer survivors: A national cohort study
      So‐Youn Jung, Young Ae Kim, Minkyung Jo, Sang Min Park, Young‐Joo Won, Haryeom Ghang, Sun‐Young Kong, Kyu‐Won Jung, Eun Sook Lee
      Cancer Medicine.2019; 8(2): 824.     CrossRef
    • Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy
      Yun-Sok Ha, Sang Won Kim, So Young Chun, Jae-Wook Chung, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Won Tae Kim, Wun-Jae Kim, Tae-Hwan Kim
      BMC Urology.2019;[Epub]     CrossRef
    • Human papillomavirus genotype-specific risk in cervical carcinogenesis
      Kyeong A So, In Ho Lee, Ki Heon Lee, Sung Ran Hong, Young Jun Kim, Hyun Hee Seo, Tae Jin Kim
      Journal of Gynecologic Oncology.2019;[Epub]     CrossRef
    • Cost for treatment and follow‐up of thyroid cancer increases according to the severity of disease
      Soo Young Kim, Seok‐Mo Kim, Hojin Chang, Bup‐Woo Kim, Yong Sang Lee, Soon‐Sun Kwon, Hyunjung Shin, Hang‐Seok Chang, Cheong Soo Park
      Head & Neck.2019; 41(7): 2376.     CrossRef
    • Methylmalonic Acid and Homocysteine as Indicators of Vitamin B12 Deficiency in Patients with Gastric Cancer after Gastrectomy
      Sae-Mi Lee, Jongwon Oh, Mi-Ryung Chun, Soo-Youn Lee
      Nutrients.2019; 11(2): 450.     CrossRef
    • Case Studies of a Structured Singing Experience for the Psychological Well-Being of Hospice Patients
      Ji Eun Oh, Hyun Ju Chong, Aimee Jeehae Kim
      Alternative and Complementary Therapies.2019; 25(2): 85.     CrossRef
    • Routine low-dose calcium supplementation after thyroidectomy does not reduce the rate of symptomatic hypocalcemia: a prospective randomized trial
      Jun Woo Lee, Jong-Kyu Kim, Hyungju Kwon, Woosung Lim, Byung-In Moon, Nam Sun Paik
      Annals of Surgical Treatment and Research.2019; 96(4): 177.     CrossRef
    • Association between sedative-hypnotic medication use and incidence of cancer in Korean Nation Health Insurance Service data
      Sun Jae Jung, Joonki Lee, Jae-Won Choi, Soohyun Kim, Aesun Shin, Yu Jin Lee
      Sleep Medicine.2019; 60: 159.     CrossRef
    • Estrogenic Activity of Sanguiin H-6 through Activation of Estrogen Receptor α Coactivator-binding Site
      Tuy An Trinh, Eun-Ji Park, Dahae Lee, Ji Hoon Song, Hye Lim Lee, Ki Hyun Kim, Younghoon Kim, Kiwon Jung, Ki Sung Kang, Jeong-Eun Yoo
      Natural Product Sciences.2019; 25(1): 28.     CrossRef
    • Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study
      Hak Min Lee, Bo Wook Kim, Seho Park, Sungmin Park, Jeon Eon Lee, Young Jin Choi, Sung Yong Kim, Sang Uk Woo, Hyun Jo Youn, Ilkyun Lee
      Breast Cancer Research and Treatment.2019; 176(2): 419.     CrossRef
    • Age-standardized expected years of life lost: quantification of cancer severity
      Yueh Wang, Chun-Ju Chiang, Wen-Chung Lee
      BMC Public Health.2019;[Epub]     CrossRef
    • Using recursive partitioning approach to select tumor‐associated antigens in immunodiagnosis of gastric adenocarcinoma
      Jiejie Qin, Shuaibing Wang, Jianxiang Shi, Yan Ma, Keyan Wang, Hua Ye, Xiaojun Zhang, Peng Wang, Xiao Wang, Chunhua Song, Liping Dai, Kaijuan Wang, Binghua Jiang, Jianying Zhang
      Cancer Science.2019; 110(6): 1829.     CrossRef
    • The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer
      Yeon-Ji Kim, Woo Chul Chung, Gun Jung Youn, Kyong-Hwa Jun, Hyung-Min Chin
      Revista Española de Enfermedades Digestivas.2019;[Epub]     CrossRef
    • Red meat intake, CYP2E1 and PPARγ polymorphisms, and colorectal cancer risk
      Na-Hui Kim, Ju Eun Seol, Jeongseon Kim, Bong-Hwa Lee, Dae-Yong Hwang, Jinyoung Jeong, Hun-Jae Lee, Yoon-Ok Ahn, Dong-Hyun Kim, Jung Eun Lee
      European Journal of Cancer Prevention.2019; 28(4): 304.     CrossRef
    • National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
      Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim
      BMC Health Services Research.2019;[Epub]     CrossRef
    • The Anti-Proliferation and Oxidative Damage-Related Mechanism of L-Carnitine in Human Colorectal Cancer Cells
      Jooyeon Lee, Jeong-Ran Park, Aera Jang, Se-Ran Yang
      Journal of Food Hygiene and Safety.2019; 34(3): 303.     CrossRef
    • Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population
      Ching-Hung Lin, Yoon Sim Yap, Kyung-Hun Lee, Seock-Ah Im, Yoichi Naito, Winnie Yeo, Takayuki Ueno, Ava Kwong, Huiping Li, Shu-Min Huang, Roland Leung, Wonshik Han, Benita Tan, Fu-Chang Hu, Chiun-Sheng Huang, Ann-Lii Cheng, Yen-Shen Lu
      JNCI: Journal of the National Cancer Institute.2019; 111(12): 1298.     CrossRef
    • Clinical Value of Lymph Node Ratio Integration with the 8th Edition of the UICC TNM Classification and 2015 ATA Risk Stratification Systems for Recurrence Prediction in Papillary Thyroid Cancer
      Jandee Lee, Seul Gi Lee, Kwangsoon Kim, Seung Hyuk Yim, Haengrang Ryu, Cho Rok Lee, Sang Wook Kang, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Young Suk Jo
      Scientific Reports.2019;[Epub]     CrossRef
    • Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer
      Hyung Soon Park, Woo Sun Kwon, Sejung Park, Eunji Jo, So Jung Lim, Choong-kun Lee, Jii Bum Lee, Minkyu Jung, Hyo Song Kim, Seung-Hoon Beom, Jun Yong Park, Tae Soo Kim, Hyun Cheol Chung, Sun Young Rha
      Journal for ImmunoTherapy of Cancer.2019;[Epub]     CrossRef
    • A simple screening score to predict diabetes in cancer patients
      Ji-Su Kim, Sun-Hye Ko, Myong Ki Baeg, Kyung-Do Han
      Medicine.2019; 98(51): e18354.     CrossRef
    • Contemporary Debates in Adult Papillary Thyroid Cancer Management
      Donald S A McLeod, Ling Zhang, Cosimo Durante, David S Cooper
      Endocrine Reviews.2019; 40(6): 1481.     CrossRef
    • Usefulness Analysis of Urine Samples for Early Screening of Human Papilloma Virus Infection
      Yoon Sung Choi, Hyunwoo Jin, Kyung Eun Lee
      Journal of Cancer Prevention.2019; 24(4): 240.     CrossRef
    • The Role of Hospital Transfer in Reexamination Computed Tomography Scans: A Nationwide Cohort Study of Gastric Cancer Patients Undergoing Surgery
      Jaeyong Shin, Yoon Jung Choi, Young Choi, Sang Gyu Lee, Ji Man Kim
      Healthcare.2019; 8(1): 2.     CrossRef
    • Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment
      Kyong-Ah Yoon, Sang Myung Woo, Yun-Hee Kim, Sun-Young Kong, Min Kyoung Lee, Sung-Sik Han, Tae Hyun Kim, Woo Jin Lee, Sang-Jae Park
      Gut and Liver.2019; 13(6): 683.     CrossRef
    • The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer
      Se-Il Go, Gyung Hyuck Ko, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
      Cancer Research and Treatment.2019; 51(4): 1411.     CrossRef
    • Iodine promotes thyroid cancer development via SPANXA1 through the PI3K/AKT signalling pathway
      Xiaoyao Yang, Jingxue Sun, Jun Han, Lulu Sun, Hongzhi Wang, Dexin Zhang, Qingxiao Fang, Jiapeng Liu, Hong Qiao
      Oncology Letters.2019;[Epub]     CrossRef
    • Correlation analysis between ultrasonography and mammography with other risk factors related to breast cancer
      Wenxiao ZhangCui Xu, Cui Xu, Rui Li, Guanghe Cui, Minmin Wang, Min Wang
      Oncology Letters.2019;[Epub]     CrossRef
    • Stilbenes contribute to the anticancer effects of Rheum�undulatum L. through activation of apoptosis
      Tuy Trinh, Dahae Lee, Seonju Park, Seung Kim, Jae Park, Ji Kim, Ki Kang
      Oncology Letters.2019;[Epub]     CrossRef
    • Social Media Use for Cancer Education at a Community-Based Cancer Center in South Korea
      Jaesung Heo, Mison Chun, Hyun Woo Lee, Jeong-Hee Woo
      Journal of Cancer Education.2018; 33(4): 769.     CrossRef
    • TERT Promoter Mutation and Telomere Length in Salivary Gland Tumors
      Heejin Kim, Dongbin Ahn, Jin Ho Sohn, Yong-Hee Kim, Jae-Ho Lee, Hyunsu Lee
      Pathology & Oncology Research.2018; 24(3): 697.     CrossRef
    • Re-stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry
      Kwang Suk Lee, Kyo Chul Koo, In Young Choi, Ji Youl Lee, Jun Hyuk Hong, Choung-Soo Kim, Hyun Moo Lee, Sung Kyu Hong, Seok-Soo Byun, Koon Ho Rha, Byung Ha Chung
      Cancer Research and Treatment.2018; 50(1): 88.     CrossRef
    • Association between adult height, myocardial infarction, heart failure, stroke and death: a Korean nationwide population-based study
      Chan Soon Park, Eue-Keun Choi, Kyung-Do Han, Hyun Jung Lee, Tae-Min Rhee, So-Ryoung Lee, Myung-Jin Cha, Woo-Hyun Lim, Si-Hyuck Kang, Seil Oh
      International Journal of Epidemiology.2018; 47(1): 289.     CrossRef
    • Right-Side Approach-Duet Totally Laparoscopic Distal Gastrectomy (R-Duet TLDG) Using a Three-Port to Treat Gastric Cancer
      Ho Seok Seo, Kyo Young Song, Yoon Ju Jung, Ji Hyun Kim, Cho Hyun Park, Han Hong Lee
      Journal of Gastrointestinal Surgery.2018; 22(4): 578.     CrossRef
    • Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
      Kwang-Beom Lee, Young Saing Kim, Jong-Min Lee
      Journal of Gynecologic Oncology.2018;[Epub]     CrossRef
    • Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys
      Jin-Kyoung Oh, Bo Yoon Jeong, E Hwa Yun, Min Kyung Lim
      Cancer Research and Treatment.2018; 50(2): 436.     CrossRef
    • Curcuzedoalide contributes to the cytotoxicity of Curcuma zedoaria rhizomes against human gastric cancer AGS cells through induction of apoptosis
      Eun Bee Jung, Tuy An Trinh, Tae Kyoung Lee, Noriko Yamabe, Ki Sung Kang, Ji Hoon Song, Sungyoul Choi, Sanghyun Lee, Tae Su Jang, Ki Hyun Kim, Gwi Seo Hwang
      Journal of Ethnopharmacology.2018; 213: 48.     CrossRef
    • Socioeconomic differences in self- and family awareness of viral hepatitis status among carriers of hepatitis B or C in rural Korea
      Hye-Ran Ahn, Sung-Bum Cho, Ik Joo Chung, Sun-Seog Kweon
      American Journal of Infection Control.2018; 46(3): 328.     CrossRef
    • Detection of early stage prostate cancer by using a simple carbon nanotube@paper biosensor
      Sungkyung Ji, Myeongsoon Lee, Don Kim
      Biosensors and Bioelectronics.2018; 102: 345.     CrossRef
    • Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors
      Sun-Hye Ko, Jung-Hee Lee, Je-Hwan Lee, Han-Seung Park, Eun-Ji Choi, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Kyoo-Hyung Lee
      Leukemia & Lymphoma.2018; 59(8): 1829.     CrossRef
    • Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
      Milind Javle, Maeve Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J. Borad, Ramesh K. Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla, Anthony El-Khoueiry, Robin Kate Kelley, Ivan Borbath, Su Pin Choo, Do-Youn Oh, Phil
      Journal of Clinical Oncology.2018; 36(3): 276.     CrossRef
    • Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis
      Alvaro Sanabria, Luiz P. Kowalski, Jatin P. Shah, Iain J. Nixon, Peter Angelos, Michelle D. Williams, Alessandra Rinaldo, Alfio Ferlito
      Head & Neck.2018; 40(4): 855.     CrossRef
    • Effect of Area-Level Deprivation on Cancer Survival Time: A Register-Based Follow-up Study of 145 585 Korean Subjects
      Minjung Kwak, Changhoon Kim
      Asia Pacific Journal of Public Health.2018; 30(1): 19.     CrossRef
    • Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis
      Jaehag Jung, Seung Hoon Lee, Mira Park, Ji Hye Youn, Sang Hoon Shin, Ho Shin Gwak, Heon Yoo
      Journal of Neuro-Oncology.2018; 137(2): 295.     CrossRef
    • Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens
      Young Ahn Yoon, Bo-Hyun Kim, Su-Hak Heo, Hwi Jun Kim, Young-Jin Choi
      Archives of Virology.2018; 163(4): 969.     CrossRef
    • Anatomical distribution and detection rate of colorectal neoplasms according to age in the colonoscopic screening of a Korean population
      Suk-young Lee, Wan Hee Song, Sang Cheul Oh, Byung-Wook Min, Sun Il Lee
      Annals of Surgical Treatment and Research.2018; 94(1): 36.     CrossRef
    • Incidence of venous thromboembolism in Korea from 2009 to 2013
      Junshik Hong, Ju Hyun Lee, Ho-Young Yhim, Won-Il Choi, Soo-Mee Bang, Heeyoung Lee, Doyeun Oh, Christophe Leroyer
      PLOS ONE.2018; 13(1): e0191897.     CrossRef
    • Epidemiology of Intracranial Metastases in Korea: A National Cohort Investigation
      Tackeun Kim, Changhoon Song, Jung Ho Han, In-Ah Kim, Yu Jung Kim, Se Hyun Kim, Jee Hyun Kim, Chae-Yong Kim
      Cancer Research and Treatment.2018; 50(1): 164.     CrossRef
    • Second Primary Cancer Risk among Kidney Cancer Patients in Korea: A Population-Based Cohort Study
      Jae Young Joung, Whi-An Kwon, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
      Cancer Research and Treatment.2018; 50(1): 293.     CrossRef
    • Development of a 4-aminopyrazolo[3,4-d]pyrimidine-based dual IGF1R/Src inhibitor as a novel anticancer agent with minimal toxicity
      Ho Jin Lee, Phuong Chi Pham, Seung Yeob Hyun, Byungyeob Baek, Byungjin Kim, Yunha Kim, Hye-Young Min, Jeeyeon Lee, Ho-Young Lee
      Molecular Cancer.2018;[Epub]     CrossRef
    • Low dietary energy intake is associated with sarcopenia in cancer survivors: An analysis based on the Korean National Health and Nutrition Examination Survey 2008–2011
      Hyoeun Kim, Sunmi Yoo, Yong Soon Park, Seung Guk Park
      Nutrition Research.2018; 53: 15.     CrossRef
    • Clinical significance of computed tomography-detected ascites in gastric cancer patients with peritoneal metastases
      Su Hwan Kim, Young Ho Choi, Ji Won Kim, Sohee Oh, Seohui Lee, Byeong Gwan Kim, Kook Lae Lee
      Medicine.2018; 97(8): e9343.     CrossRef
    • Interaction between alcohol consumption and methylenetetrahydrofolate reductase polymorphisms in thyroid cancer risk: National Cancer Center cohort in Korea
      Sarah Yang, Jeonghee Lee, Yoon Park, Eun Kyung Lee, Yul Hwangbo, Junsun Ryu, Joohon Sung, Jeongseon Kim
      Scientific Reports.2018;[Epub]     CrossRef
    • Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori Infection
      Jae Hyun Jung, In Kuk Cho, Chang Hee Lee, Gwan Gyu Song, Ji Hyun Lim
      Gut and Liver.2018; 12(2): 165.     CrossRef
    • Novel Systemic Therapies for Advanced Gastric Cancer
      Hong Jun Kim, Sang Cheul Oh
      Journal of Gastric Cancer.2018; 18(1): 1.     CrossRef
    • The role of bevacizumab on tumour angiogenesis and in the management of gynaecological cancers: A review
      Dinesh Kumar Chellappan, Kun Hooi Leng, Lee Jia Jia, Nur Amirah Binti Abdul Aziz, Wong Chun Hoong, Yap Cheng Qian, Fam Yi Ling, Gwee Sing Wei, Tiong Ying, Jestin Chellian, Gaurav Gupta, Kamal Dua
      Biomedicine & Pharmacotherapy.2018; 102: 1127.     CrossRef
    • Genome‐wide profiling of normal gastric mucosa identifies Helicobacter pylori‐ and cancer‐associated DNA methylome changes
      Hae Dong Woo, Nora Fernandez‐Jimenez, Akram Ghantous, Davide Degli Esposti, Cyrille Cuenin, Vincent Cahais, Il Ju Choi, Young‐Il Kim, Jeongseon Kim, Zdenko Herceg
      International Journal of Cancer.2018; 143(3): 597.     CrossRef
    • Efficacy of a clinical pathway for patients with thyroid cancer
      Hyungju Kwon, Joon‐Hyop Lee, Joohyun Woo, Woosung Lim, Byung‐In Moon, Nam Sun Paik
      Head & Neck.2018; 40(9): 1909.     CrossRef
    • Associations between genetic polymorphisms of membrane transporter genes and prognosis after chemotherapy: meta-analysis and finding from Seoul Breast Cancer Study (SEBCS)
      Ji-Eun Kim, Jaesung Choi, JooYong Park, Chulbum Park, Se Mi Lee, Seong Eun Park, Nan Song, Seokang Chung, Hyuna Sung, Wonshik Han, Jong Won Lee, Sue K. Park, Mi Kyung Kim, Dong-Young Noh, Keun-Young Yoo, Daehee Kang, Ji-Yeob Choi
      The Pharmacogenomics Journal.2018; 18(5): 633.     CrossRef
    • Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea
      Yuh-Seog Jung, Chang-Mo Oh, Yeol Kim, Kyu-Won Jung, Junsun Ryu, Young-Joo Won, Pierlorenzo Pallante
      PLOS ONE.2018; 13(4): e0194743.     CrossRef
    • Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy
      Kyu Hye Choi, Ji Yoon Kim, Dong Soo Lee, Yun Hee Lee, Sea-Won Lee, SooYoon Sung, Hee Hyun Park, Sei-Chul Yoon, Soo Young Hur, Jong-Sup Park, Yeon Sil Kim
      Medicine.2018; 97(16): e0517.     CrossRef
    • Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea
      Sang‐Wook Yi, Ja‐Sung Choi, Jee‐Jeon Yi, Yong‐ho Lee, Ki Jun Han
      Cancer.2018; 124(13): 2748.     CrossRef
    • The Effectiveness of Problem-Solving Therapy Program Intervention in Reducing Depression of Older Cancer Patients
      Hyunsook Yoon, Yojin Kim, Kyoungwon Choi, Yeon Ok Lim, Ilsung Nam, Woonjeong Kim, Hyejin Ham
      Korean Journal of Health Promotion.2018; 18(1): 60.     CrossRef
    • A panel consisting of three novel circulating lncRNAs, is it a predictive tool for gastric cancer?
      Jingjing Liu, Jiajun Wang, Yongxi Song, Bin Ma, Junlong Luo, Zhongran Ni, Peng Gao, Jingxu Sun, Junhua Zhao, Xiaowan Chen, Zhenning Wang
      Journal of Cellular and Molecular Medicine.2018; 22(7): 3605.     CrossRef
    • Hierarchical structural component modeling of microRNA-mRNA integration analysis
      Yongkang Kim, Sungyoung Lee, Sungkyoung Choi, Jin-Young Jang, Taesung Park
      BMC Bioinformatics.2018;[Epub]     CrossRef
    • Projection of Breast Cancer Burden due to Reproductive/Lifestyle Changes in Korean Women (2013-2030) Using an Age-Period-Cohort Model
      Joo Eun Lee, Sang Ah Lee, Tae Hyun Kim, Sohee Park, Yoon Soo Choy, Yeong Jun Ju, Eun-Cheol Park
      Cancer Research and Treatment.2018; 50(4): 1388.     CrossRef
    • Dietary pattern and health-related quality of life among breast cancer survivors
      Na-Hui Kim, Sihan Song, So-Youn Jung, Eunsook Lee, Zisun Kim, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
      BMC Women's Health.2018;[Epub]     CrossRef
    • Trends in Gallbladder Cancer Incidence and Survival in Korea
      Youngjun Wi, Hyeongtaek Woo, Young-Joo Won, Jin-Young Jang, Aesun Shin
      Cancer Research and Treatment.2018; 50(4): 1444.     CrossRef
    • Development of an Algorithm for Stroke Prediction: A National Health Insurance Database Study in Korea
      Seung Nam Min, Se Jin Park, Dong Joon Kim, Murali Subramaniyam, Kyung-Sun Lee
      European Neurology.2018; 79(3-4): 214.     CrossRef
    • Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis
      Kwan-Il Kim, Ji Hee Jun, Hyunjung Baek, Jae-Hyo Kim, Beom-Joon Lee, Hee-Jae Jung, Francesca Borrelli
      PLOS ONE.2018; 13(5): e0198015.     CrossRef
    • A prospective pilot evaluation of vaginal and urine self-sampling for the Roche cobas 4800 HPV test for cervical cancer screening
      Sang-Hyun Hwang, Hye Young Shin, Dong Ock Lee, Na Young Sung, Bomyee Lee, Do-Hoon Lee, Jae Kwan Jun
      Scientific Reports.2018;[Epub]     CrossRef
    • Incidence of Diabetes After Cancer Development
      Yul Hwangbo, Danbee Kang, Minwoong Kang, Saemina Kim, Eun Kyung Lee, Young Ae Kim, Yoon Jung Chang, Kui Son Choi, So-Youn Jung, Sang Myung Woo, Jin Seok Ahn, Sung Hoon Sim, Yun Soo Hong, Roberto Pastor-Barriuso, Eliseo Guallar, Eun Sook Lee, Sun-Young Kon
      JAMA Oncology.2018; 4(8): 1099.     CrossRef
    • Effect of psychosocial interventions on the quality of life of patients with colorectal cancer: a systematic review and meta-analysis
      Heesook Son, Youn-Jung Son, Hyerang Kim, Yoonju Lee
      Health and Quality of Life Outcomes.2018;[Epub]     CrossRef
    • Are pregnancy, parity, menstruation and breastfeeding risk factors for thyroid cancer? Results from the Korea National Health and Nutrition Examination Survey, 2010‐2015
      Hosu Kim, Kyong Young Kim, Jong Ha Baek, Jaehoon Jung
      Clinical Endocrinology.2018; 89(2): 233.     CrossRef
    • Estimation of the medical need for carbon-ion radiotherapy in Korea
      Ilsung Cho, Young Seok Seo, WonGyun Jung, Mi-sook Kim
      Journal of Radiation Research.2018; 59(5): 588.     CrossRef
    • Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up
      Hyae Young Kim, Kyu-Won Jung, Kun Young Lim, Soo-Hyun Lee, Jae Kwan Jun, Jeongseon Kim, Bin Hwangbo, Jin Soo Lee
      Cancer Research and Treatment.2018; 50(3): 748.     CrossRef
    • The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma
      Sea-Won Lee, Jong Hoon Lee, In Kyu Lee, Seong Taek Oh, Dae Yong Kim, Tae Hyun Kim, Jae Hwan Oh, Ji Yeon Baek, Hee Jin Chang, Hee Chul Park, Hee Cheol Kim, Eui Kyu Chie, Taek-Keun Nam, Hong Seok Jang
      Cancer Research and Treatment.2018; 50(3): 1039.     CrossRef
    • Nationwide Trends in the Incidence of Melanoma and Non-melanoma Skin Cancers from 1999 to 2014 in South Korea
      Chang-Mo Oh, Hyunsoon Cho, Young-Joo Won, Hyun-Joo Kong, Yun Ho Roh, Ki-Heon Jeong, Kyu-Won Jung
      Cancer Research and Treatment.2018; 50(3): 729.     CrossRef
    • Utility of the National Lung Screening Trial Criteria for Estimation of Lung Cancer in the Korean Population
      Ye Jin Lee, Sun Mi Choi, Jinwoo Lee, Chang-Hoon Lee, Sang-Min Lee, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Young Sik Park
      Cancer Research and Treatment.2018; 50(3): 950.     CrossRef
    • The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer
      Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
      Cancer Research and Treatment.2018; 50(3): 720.     CrossRef
    • The neutrophil-to-lymphocyte ratio makes the Heng risk model improve better the prediction of overall survival in metastatic renal cell cancer patients
      Sung Han Kim, Whi-An Kwon, Sohee Kim, Jae Young Joung, Ho Kyung Seo, Kang Hyun Lee, Jinsoo Chung
      Japanese Journal of Clinical Oncology.2018; 48(9): 835.     CrossRef
    • Risk of Coronary Heart Disease and Ischemic Stroke Incidence in Gastric Cancer Survivors: A Nationwide Study in Korea
      Dong Wook Shin, Beomseok Suh, Youngmin Park, Hyunsun Lim, Yun-Suhk Suh, Jae Moon Yun, BeLong Cho, Han-Kwang Yang
      Annals of Surgical Oncology.2018; 25(11): 3248.     CrossRef
    • Prognostic Factors of Penile Cancer and the Efficacy of Adjuvant Treatment after Penectomy: Results from a Multi-institution Study
      Jong Won Kim, Young Sig Kim, Woo Jin Ko, Young Deuk Choi, Sung Joon Hong, Byung Ha Chung, Kwang Suk Lee
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Incidence of gallstones after gastric resection for gastric cancer: a nationwide claims-based study
      Gi Hyeon Seo, Chang-Sup Lim, Young Jun Chai
      Annals of Surgical Treatment and Research.2018; 95(2): 87.     CrossRef
    • Fermented Ganjangs (Soy Sauce and Sesame Sauce) Attenuates Colonic Carcinogenesis in Azoxymethane/Dextran Sodium Sulfate-Treated C57BL/6J Mice
      Jia-Le Song, Jung-Ho Choi, Jae-Hoon Seo, Kun-Young Park
      Journal of Medicinal Food.2018; 21(9): 905.     CrossRef
    • Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer
      Jong Soo Lee, Young Saing Kim, Eun Young Kim, Wook Jin, Cesario Bianchi
      PLOS ONE.2018; 13(8): e0202700.     CrossRef
    • FOXO3a expression is associated with lymph node metastasis and poor disease-free survival in triple-negative breast cancer
      Abdul Rehman, Yeseul Kim, Hyunsung Kim, Jongmin Sim, Hyein Ahn, Min Sung Chung, Su-Jin Shin, Kiseok Jang
      Journal of Clinical Pathology.2018; 71(9): 806.     CrossRef
    • High RNA-binding Motif Protein 3 Expression Is Associated with Improved Clinical Outcomes in Invasive Breast Cancer
      Sun Hee Kang, Jihyoung Cho, Hasong Jeong, Sun Young Kwon
      Journal of Breast Cancer.2018; 21(3): 288.     CrossRef
    • Outcomes of liver resection in patients with colorectal liver metastases by laparoscopic or open surgery
      Jae-Ryong Shim, Seung Duk Lee, Hyung-Min Park, Eung-Chang Lee, Boram Park, Sung-Sik Han, Seong Hoon Kim, Sang Jae Park
      Annals of Hepato-Biliary-Pancreatic Surgery.2018; 22(3): 223.     CrossRef
    • Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma
      Su Hwan Kim, Ji Won Kim, Kook Lae Lee, Seohui Lee, Seong-Joon Koh, Ji Bong Jeong, Byeong Gwan Kim
      The American Journal of the Medical Sciences.2018; 356(2): 141.     CrossRef
    • Analysis of red blood cell use in elective surgeries over 12 years in Korea
      Banseok Kim, Yongjung Park, Young Ah Kim, Minjin Kang, Sinyoung Kim, Hyun Ok Kim
      Transfusion.2018; 58(10): 2335.     CrossRef
    • Effect of tibolone on the survival of early stage cervical adenocarcinoma patients
      Seung-Ho Lee, Yoon-Jin Cho, Kyung-Joo Cho, Mee-Hyang Ko, Sun-Young Jung, Seung-Joo Chon, So-Yi Lim, Kwang-Beom Lee
      Obstetrics & Gynecology Science.2018; 61(5): 584.     CrossRef
    • Trend analysis of major cancer statistics according to sex and severity levels in Korea
      Minsu Ock, Woong Jae Choi, Min-Woo Jo, Antonio Palazón-Bru
      PLOS ONE.2018; 13(9): e0203110.     CrossRef
    • Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial
      Chansik An, Do Young Kim, Jin-Young Choi, Kwang Hyub Han, Yun Ho Roh, Myeong-Jin Kim
      BMC Cancer.2018;[Epub]     CrossRef
    • The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol
      Chang eun Jang, Mi Sook Jung, Eun Hee Sohn, Mijung Kim, Hwa-Seung Yoo, Kyeore Bae, Je Ryong Kim, Jin Sun Lee
      Trials.2018;[Epub]     CrossRef
    • Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
      Il Yong Chung, Jihyoun Lee, Suyeon Park, Jong Won Lee, Hyun Jo Youn, Jung Hwa Hong, Ho Hur
      Journal of Korean Medical Science.2018;[Epub]     CrossRef
    • Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma
      Kwangsoon Kim, Won Woong Kim, Jung Bum Choi, Min Jhi Kim, Cho Rok Lee, Jandee Lee, Sang-Wook Kang, Kee-Hyun Nam, Woong Youn Chung, Jong Ju Jeong
      Annals of Surgical Treatment and Research.2018; 95(4): 222.     CrossRef
    • Secondary Breast, Ovarian, and Uterine Cancers After Colorectal Cancer: A Nationwide Population-Based Cohort Study in Korea
      Dong Woo Shin, Yoon Jin Choi, Hyun Soo Kim, Kyung-Do Han, Hyuk Yoon, Young Soo Park, Nayoung Kim, Dong Ho Lee
      Diseases of the Colon & Rectum.2018; 61(11): 1250.     CrossRef
    • The da Vinci Xi System in Robotic Gastric Cancer Surgery: A Comparison with the S System
      Chulhyo Jeon, Ho Seok Seo, Yoon Ju Jung, Cho Hyun Park, Kyo Young Song
      The Journal of Minimally Invasive Surgery.2018; 21(3): 112.     CrossRef
    • Induction of apoptosis and G1 phase cell cycle arrest by Aster�incises in AGS gastric adenocarcinoma cells
      Daniel Ngabire, Yeong-Ae Seong, Maheshkumar Prakash Patil, Irvine Niyonizigiye, Yong Bae Seo, Gun-Do Kim
      International Journal of Oncology.2018;[Epub]     CrossRef
    • Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer
      Seungho Lee, Seowon Choi, Yookyung Lee, Donghae Chung, Suntaek Hong, Nohhyun Park
      Journal of Obstetrics and Gynaecology Research.2017; 43(1): 220.     CrossRef
    • Effect of number of retrieved lymph nodes on prognosis in FIGO stage IB–IIA cervical cancer patients treated with primary radical surgery
      Soyi Lim, Kyungjoo Cho, Seungho Lee, Kwangbeom Lee, Jinwoo Shin, Donghae Chung, Chanyong Park
      Journal of Obstetrics and Gynaecology Research.2017; 43(1): 211.     CrossRef
    • Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution
      Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang
      Cancer Research and Treatment.2017; 49(2): 473.     CrossRef
    • Suicidal ideation and suicidal attempts among adults with chronic diseases: A cross-sectional study
      Su-Yeon Kye, Keeho Park
      Comprehensive Psychiatry.2017; 73: 160.     CrossRef
    • 5-Fluorouracil inhibits cell migration by induction of Sestrin2 in colon cancer cells
      Kyuhwa Seo, Sung Hwan Ki, Eun Young Park, Sang Mi Shin
      Archives of Pharmacal Research.2017; 40(2): 231.     CrossRef
    • Psychiatric comorbidities among breast cancer survivors in South Korea: a nationwide population-based study
      Jaesung Heo, Mison Chun, Young-Taek Oh, O. Kyu Noh, Logyoung Kim
      Breast Cancer Research and Treatment.2017; 162(1): 151.     CrossRef
    • Atrophic and Metaplastic Progression in the Background Mucosa of Patients with Gastric Adenoma
      Hee Kyong Na, Charles J. Cho, Suh Eun Bae, Jeong Hoon Lee, Young Soo Park, Ji Yong Ahn, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Se Jin Jang, Hwoon-Yong Jung, Pal Bela Szecsi
      PLOS ONE.2017; 12(1): e0169456.     CrossRef
    • 125I–F56 Peptide as Radioanalysis Agent Targeting VEGFR1 in Mice Xenografted with Human Gastric Tumor
      Hua Zhu, Chuanke Zhao, Fei Liu, Lixin Wang, Junnan Feng, Chengchao Shou, Zhi Yang
      ACS Medicinal Chemistry Letters.2017; 8(2): 266.     CrossRef
    • Thyroid fine-needle aspiration biopsy positively correlates with increased diagnosis of thyroid cancer in South Korean patients
      Yoon Jae Cho, Do Young Kim, Eun-Cheol Park, Kyu-Tae Han
      BMC Cancer.2017;[Epub]     CrossRef
    • Survival Rate and Associated Factors of Childhood Leukemia in Iran: A Systematic Review and Meta Analysis
      Yousef Veisani, Ali Delpisheh
      Journal of Pediatrics Review.2017;[Epub]     CrossRef
    • Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
      Hyung Soon Park, Joohyuk Sohn, Seung Il Kim, Seho Park, Hyung Seok Park, Seul Ghi Gho, Hyun Cheol Chung, Soonmyung Paik, Gun Min Kim
      Breast Cancer Research and Treatment.2017; 163(2): 255.     CrossRef
    • Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
      Sang Joon Park, Jae Young Jang, Soung Won Jeong, Young Kyu Cho, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Hae In Bang
      Medicine.2017; 96(11): e5811.     CrossRef
    • Outcomes of laparoscopic surgery in pathologic T4 colon cancers compared to those of open surgery
      Jeonghyun Kang, Seung Hyuk Baik, Kang Young Lee, Seung-Kook Sohn
      International Journal of Colorectal Disease.2017; 32(4): 531.     CrossRef
    • The Effect of Endoscopic Resection on Short-Term Surgical Outcomes in Patients with Additional Laparoscopic Gastrectomy after Non-Curative Resection for Gastric Cancer
      Eun-Gyeong Lee, Keun-Won Ryu, Bang-Wool Eom, Hong-Man Yoon, Yong-Il Kim, Soo-Jeong Cho, Jong-Yeul Lee, Chan-Gyoo Kim, Il-Ju Choi, Young-Woo Kim
      Journal of Gastric Cancer.2017; 17(1): 33.     CrossRef
    • Molecular Testing for Gastrointestinal Cancer
      Hye Seung Lee, Woo Ho Kim, Yoonjin Kwak, Jiwon Koh, Jeong Mo Bae, Kyoung-Mee Kim, Mee Soo Chang, Hye Seung Han, Joon Mee Kim, Hwal Woong Kim, Hee Kyung Chang, Young Hee Choi, Ji Y. Park, Mi Jin Gu, Min Jin Lhee, Jung Yeon Kim, Hee Sung Kim, Mee-Yon Cho
      Journal of Pathology and Translational Medicine.2017; 51(2): 103.     CrossRef
    • Mesothelin Expression in Gastric Adenocarcinoma and Its Relation to Clinical Outcomes
      Song-Hee Han, Mee Joo, Hanseong Kim, Sunhee Chang
      Journal of Pathology and Translational Medicine.2017; 51(2): 122.     CrossRef
    • The light and shade of the cancer care system in Korea
      Byung Soh Min
      Journal of the Korean Medical Association.2017; 60(3): 217.     CrossRef
    • Proposal for improving the outcomes of cancer treatment
      Hyung Jin Kim
      Journal of the Korean Medical Association.2017; 60(3): 219.     CrossRef
    • Genetic Predisposition of Polymorphisms inHMGB1-Related Genes to Breast Cancer Prognosis in Korean Women
      Junsu Lee, Jaesung Choi, Seokang Chung, JooYong Park, Ji-Eun Kim, Hyuna Sung, Wonshik Han, Jong Won Lee, Sue K. Park, Mi Kyung Kim, Sei-Hyun Ahn, Dong-Young Noh, Keun-Young Yoo, Daehee Kang, Ji-Yeob Choi
      Journal of Breast Cancer.2017; 20(1): 27.     CrossRef
    • Long-term outcomes after salvage radiotherapy for postoperative locoregionally recurrent non-small-cell lung cancer
      Eunji Kim, Changhoon Song, Mi Young Kim, Jae-Sung Kim
      Radiation Oncology Journal.2017; 35(1): 55.     CrossRef
    • Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress
      Eun Hwa Park, Sun Young Min, Zisun Kim, Chan Seok Yoon, Kyu-Won Jung, Seok Jin Nam, Se Jeong Oh, Seeyoun Lee, Byeong-Woo Park, Woosung Lim, Min Hee Hur
      Journal of Breast Cancer.2017; 20(1): 1.     CrossRef
    • Factors Affecting the “Locus of Responsibility” in Cancer News: Focusing on the Role of Health Journalists’ Medical Expertise in South Korea
      Yong-Chan Kim, Minsun Shim, Jee Hyun Kim, Keeho Park
      Journalism & Mass Communication Quarterly.2017; 94(2): 465.     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014
      Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee
      Cancer Research and Treatment.2017; 49(2): 292.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2017
      Kyu-Won Jung, Young-Joo Won, Chang-Mo Oh, Hyun-Joo Kong, Duk Hyoung Lee, Kang Hyun Lee
      Cancer Research and Treatment.2017; 49(2): 306.     CrossRef
    • The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma
      Wook Youn Kim, Seung-Hyuk Shim, Ho Young Jung, Meari Dong, Soo-Nyung Kim, Sun Joo Lee
      Human Pathology.2017; 64: 98.     CrossRef
    • Semi‐end‐to‐end esophagojejunostomy after laparoscopy‐assisted total gastrectomy better reduces stricture and leakage than the conventional end‐to‐side procedure: A retrospective study
      Wei Duan, Kaijun Liu, Xiaolong Fu, Xuqi Shen, Jun Chen, Chongyu Su, Peiwu Yu, Yongliang Zhao
      Journal of Surgical Oncology.2017; 116(2): 177.     CrossRef
    • Occipital Lobe Metastasis of Hepatocellular Carcinoma Presenting as Homonymous Hemianopia
      Hye Jin Lee, Young Hee Maeng, Jinho Jeong, You-Nam Chung, Chang Sub Lee, Byung-Cheol Song
      Journal of the Korean Ophthalmological Society.2017; 58(4): 488.     CrossRef
    • Psycho-oncology in Korea: past, present and future
      Hyun Jeong Lee, Kwang-Min Lee, Dooyoung Jung, Eun-Jung Shim, Bong-Jin Hahm, Jong-Heun Kim
      BioPsychoSocial Medicine.2017;[Epub]     CrossRef
    • Risk factors and the preoperative assessment of right para-oesophageal lymph node metastasis in right lobe papillary thyroid carcinoma: A case series
      You Qu, Hao Zhang, Ping Zhang, Wenwu Dong, Liang He, Wei Sun, Jinhao Liu
      International Journal of Surgery.2017; 42: 123.     CrossRef
    • Care Pathway for Cancer Survivorship in Korea: Trend of Breast Cancer Pathway from 2003 to 2010
      Hwa Jeong Seo, Dong Yong Noh
      Healthcare Informatics Research.2017; 23(2): 119.     CrossRef
    • Practice Patterns of Hereditary Ovarian Cancer Management in Korea
      Min Chul Choi, Myong Cheol Lim, Maria Lee, Min Kyu Kim, Dong Hoon Suh, Yong Jung Song, Tae-Joong Kim, Suk-Joon Chang, Jae-Weon Kim
      International Journal of Gynecological Cancer.2017; 27(5): 895.     CrossRef
    • Isofraxidin inhibited proliferation and induced apoptosis via blockage of Akt pathway in human colorectal cancer cells
      Peng Shen, Hong-Gang Wang, Miao-Miao Li, Qian-Yun Ma, Chuan-Wen Zhou, Feng Pan, Rui Xie
      Biomedicine & Pharmacotherapy.2017; 92: 78.     CrossRef
    • Micrometastasis in Gastric Cancer
      Gun Jung Youn, Woo Chul Chung
      The Korean Journal of Gastroenterology.2017; 69(5): 270.     CrossRef
    • Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status
      Youngjoo Lee, Ji-Youn Han, Sung Ho Moon, Byung-Ho Nam, Kun Young Lim, Geon Kook Lee, Heung Tae Kim, Tak Yun, Hye Jin An, Jin Soo Lee
      Cancer Research and Treatment.2017; 49(4): 981.     CrossRef
    • Treatment of Refractory Colorectal Cancer: Regorafenib vs. TAS-102
      Jae Ho Jeong, Yong Sang Hong, Tae Won Kim
      Current Colorectal Cancer Reports.2017; 13(4): 325.     CrossRef
    • Hormone Therapy for Metastatic Breast Cancer
      Seok Yun Kang
      The Korean Journal of Medicine.2017; 92(3): 251.     CrossRef
    • Prognostic impact of Ki-67 in patients with gastric cancer—the importance of depth of invasion and histologic differentiation
      Gyung Hyuck Ko, Se-Il Go, Won Sup Lee, Jeong-Hee Lee, Sang-Ho Jeong, Young-Joon Lee, Soon Chan Hong, Woo Song Ha
      Medicine.2017; 96(25): e7181.     CrossRef
    • Clinical characteristics of second primary pancreatic cancer
      Jung Hyun Jo, In Rae Cho, Jang Han Jung, Hee Seung Lee, Moon Jae Chung, Seungmin Bang, Seung Woo Park, Jae Bock Chung, Si Young Song, Jeong Youp Park, Masaru Katoh
      PLOS ONE.2017; 12(6): e0179784.     CrossRef
    • Effects of Soy Product Intake and Interleukin Genetic Polymorphisms on Early Gastric Cancer Risk in Korea: A Case-Control Study
      Sarah Yang, Yoon Park, Jeonghee Lee, Il Ju Choi, Young Woo Kim, Keun Won Ryu, Joohon Sung, Jeongseon Kim
      Cancer Research and Treatment.2017; 49(4): 1044.     CrossRef
    • Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
      Hyung Soon Park, Ji Soo Park, You Jin Chun, Yun Ho Roh, Jieun Moon, Hong Jae Chon, Hye Jin Choi, Joon Seong Park, Dong Ki Lee, Se-Joon Lee, Dong Sup Yoon, Hei-Cheul Jeung
      Cancer Research and Treatment.2017; 49(4): 1127.     CrossRef
    • Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis
      Hye-Ryoun Kim, Seo Yun Kim, Cheol Hyeon Kim, Sung Hyun Yang, Jae Cheol Lee, Chang-Min Choi, Im Il Na
      Journal of Cancer Research and Clinical Oncology.2017; 143(11): 2283.     CrossRef
    • A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
      Sung Hee Lim, Young Mog Shim, Se Hoon Park, Hong Kwan Kim, Young Soo Choi, Myung-Ju Ahn, Keunchil Park, Jae Ill Zo, Jong-Mu Sun
      Cancer Research and Treatment.2017; 49(3): 816.     CrossRef
    • Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer
      Ho-Young Son, Yul Hwangbo, Seong-Keun Yoo, Sun-Wha Im, San Duk Yang, Soo-Jung Kwak, Min Seon Park, Soo Heon Kwak, Sun Wook Cho, Jun Sun Ryu, Jeongseon Kim, Yuh-Seog Jung, Tae Hyun Kim, Su-jin Kim, Kyu Eun Lee, Do Joon Park, Nam Han Cho, Joohon Sung, Jeong
      Nature Communications.2017;[Epub]     CrossRef
    • A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
      Sook Ryun Park, Mi-Jung Kim, Byung-Ho Nam, Chan Gyoo Kim, Jong Yeul Lee, Soo-Jeong Cho, Sun-Young Kong, Young-Iee Park
      European Journal of Cancer.2017; 83: 32.     CrossRef
    • Quality of life among Korean gastrointestinal cancer survivors
      Soojung Ahn, Hyejeong Jung, Sanghee Kim, Sang Joon Shin, Chang Gi Park, Sang Hui Chu
      European Journal of Oncology Nursing.2017; 30: 15.     CrossRef
    • Joint Symposium of Korean Cancer Association & UICC-ARO—Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia
      Eun-Cheol Park, Norie Kawahara, Shinjiro Nozaki, Hasbullah Thabrany, Shunya Yoshimi, Sohee Park, Duk Hyoung Lee, Hideyuki Akaza, Jae Kyung Roh
      Japanese Journal of Clinical Oncology.2017; 47(9): 889.     CrossRef
    • The serum pepsinogen levels for risk assessment of gastric neoplasms
      Jun-Hyung Cho, Seong Ran Jeon, Hyun Gun Kim, So-Young Jin, Suyeon Park
      Medicine.2017; 96(29): e7603.     CrossRef
    • Differential proteome expression analysis of androgen-dependent and -independent pathways in LNCaP prostate cancer cells
      Seho Cha, Dong Hoon Shin, Jun Ryeong Seok, Jae Kyung Myung
      Experimental Cell Research.2017; 359(1): 215.     CrossRef
    • Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea
      Sung Geun Kim, Ho Seok Seo, Han Hong Lee, Kyo Yong Song, Cho Hyun Park
      Journal of Gastric Cancer.2017; 17(3): 212.     CrossRef
    • Family history of gastric cancer is associated with the risk of colorectal neoplasia in Korean population
      Yoon Suk Jung, Nam Hee Kim, Hyo-Joon Yang, Soo-Kyung Park, Jung Ho Park, Dong Il Park, Chong Il Sohn
      Digestive and Liver Disease.2017; 49(10): 1155.     CrossRef
    • A Comparison of Symptoms, Depression, and Quality of Life according to Stages of Survivorship in Lung Cancer Patients
      Yoon Jung Chae, Jeong Sook Park
      Asian Oncology Nursing.2017; 17(2): 79.     CrossRef
    • Unusual Contralateral Axillary Lymph Node Metastasis in a Second Primary Breast Cancer Detected by FDG PET/CT and Lymphoscintigraphy
      Ji-Young Kim, Hyunjong Lee, Tae Sung Kim, Han-Sung Kang, Seok-ki Kim
      Nuclear Medicine and Molecular Imaging.2017; 51(4): 350.     CrossRef
    • Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data
      Yun Mi Choi, Won Gu Kim, Hyemi Kwon, Min Ji Jeon, Minkyu Han, Tae Yong Kim, Young Kee Shong, Sang Mo Hong, Eun‐Gyoung Hong, Won Bae Kim
      Cancer.2017; 123(24): 4808.     CrossRef
    • Proposal for Comprehensive Quality Control of Heavy-Ion Medical Accelerator
      Dong-wook Kim, Dong-oh Shin, Young-hoon Shin, Hyun-do Heo
      Progress in Medical Physics.2017; 28(2): 67.     CrossRef
    • Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033
      Kyeong Min Kwak, Domyung Paek, Seung-sik Hwang, Young-Su Ju, Mark Allen Pershouse
      PLOS ONE.2017; 12(8): e0183404.     CrossRef
    • Recent advances in pharmacological research on Ecklonia species: a review
      Prashamsa Koirala, Hyun Ah Jung, Jae Sue Choi
      Archives of Pharmacal Research.2017; 40(9): 981.     CrossRef
    • Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer
      Joo Won Chung, Moon Jae Chung, Seungmin Bang, Seung Woo Park, Si Young Song, Jae Bock Chung, Jeong Youp Park
      Gut and Liver.2017; 11(5): 728.     CrossRef
    • Esophageal Squamous Cell Carcinoma Presenting as a Subepithelial Tumor
      Soon Young Kim, Sang Kil Lee, Hyang Joo Ryu
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(3): 144.     CrossRef
    • Factors for improving the diagnostic efficiency of the rapid urease test from the gastric corpus
      Jun-Hyung Cho, Seong Ran Jeon, Hyun Gun Kim, So-Young Jin, Suyeon Park
      Scandinavian Journal of Gastroenterology.2017; 52(12): 1320.     CrossRef
    • Updated guidelines on the preoperative staging of thyroid cancer
      Hye Jung Kim
      Ultrasonography.2017; 36(4): 292.     CrossRef
    • Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
      Seeyoun Lee, In Hae Park, Seho Park, Joohyuk Sohn, Joon Jeong, Sung Gwe Ahn, Ik Jae Lee, Hae Kyung Lee, Seung Ah Lee, Won Park, Kyung-Hun Lee, Sung-Won Kim, Sang-Ah Han, Kyung Hae Jung, Byung Ho Son
      Journal of Breast Cancer.2017; 20(3): 228.     CrossRef
    • Validation Study for the Korean Version of Fear of Cancer Recurrence Inventory
      Jinyoung Shin, Aejin Goo, Hyeonyoung Ko, Ji-Hae Kim, Seung-U Lim, Han-Kyeong Lee, Sébastien Simard, Yun-Mi Song
      Journal of Korean Medical Science.2017; 32(11): 1792.     CrossRef
    • Circulating folate levels and colorectal adenoma: a case-control study and a meta-analysis
      Yeong Mi Park, Jiyoung Youn, Chang Ho Cho, Sung Hi Kim, Jung Eun Lee
      Nutrition Research and Practice.2017; 11(5): 419.     CrossRef
    • Current Management of Benign Epithelial Gastric Polyps
      Antonio R. Cheesman, David A. Greenwald, Shailja C. Shah
      Current Treatment Options in Gastroenterology.2017; 15(4): 676.     CrossRef
    • The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea
      Yoon Jin Choi, Dong Ho Lee, Kyung-Do Han, Hyun Soo Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, John Green
      PLOS ONE.2017; 12(10): e0185778.     CrossRef
    • Second primary cancer after liver transplantation in hepatocellular carcinoma: a nationwide population-based study
      Jaesung Heo, O. Kyu Noh, Young-Taek Oh, Mison Chun, Logyoung Kim
      Hepatology International.2017; 11(6): 523.     CrossRef
    • Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population
      Jonggi Choi, Seungbong Han, Namkug Kim, Young‐Suk Lim
      Hepatology.2017; 66(5): 1454.     CrossRef
    • Propensity score-matched analysis of the endoscopic bilateral axillo-breast approach (BABA) versus conventional open thyroidectomy in patients with benign or intermediate fine-needle aspiration cytology results, a retrospective study
      Mansoor Alramadhan, Jun Ho Choe, Jun Ho Lee, Jung Han Kim, Jee Soo Kim
      International Journal of Surgery.2017; 48: 9.     CrossRef
    • Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination
      Sung Uk Lee, Kwan Ho Cho
      Radiation Oncology Journal.2017; 35(3): 189.     CrossRef
    • Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
      Jang Ho Cho, Jae Yun Lim, Jae Yong Cho, Masaru Katoh
      PLOS ONE.2017; 12(10): e0186362.     CrossRef
    • Survival outcome and prognostic factors of neoadjuvant treatment followed by resection for borderline resectable pancreatic cancer
      Hyeong Seok Kim, Jin-Young Jang, Youngmin Han, Kyoung Bun Lee, Ijin Joo, Doo-Ho Lee, Jae Ri Kim, Hongbeom Kim, Wooil Kwon, Sun-Whe Kim
      Annals of Surgical Treatment and Research.2017; 93(4): 186.     CrossRef
    • Experience of Chemotherapy in Ovarian Cancer Patients
      Nayeon Shin, Jiyoung Kim
      Asian Oncology Nursing.2017; 17(3): 158.     CrossRef
    • Establishment of Korean prostate cancer database by the Korean Urological Oncology Society
      Hanjong Ahn, Hyung Jin Kim, Seong Soo Jeon, Cheol Kwak, Gyung Tak Sung, Tae Gyun Kwon, Jong Yeon Park, Sung Hyun Paick
      Investigative and Clinical Urology.2017; 58(6): 434.     CrossRef
    • Accuracy of Preoperative Local Staging of Primary Colorectal Cancer by Using Computed Tomography: Reappraisal Based on Data Collected at a Highly Organized Cancer Center
      Jung Sub So, Chinock Cheong, Seung Yeop Oh, Jei Hee Lee, Young Bae Kim, Kwang Wook Suh
      Annals of Coloproctology.2017; 33(5): 192.     CrossRef
    • Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression
      Byung-Kyu Ryu, Min-Goo Lee, Nam-Hoon Kim, Kil Yeon Lee, Shin-Ju Oh, Jung-Rock Moon, Hyo Jong Kim, Sung-Gil Chi
      BMC Cancer.2017;[Epub]     CrossRef
    • Pancreatic Neuroendocrine Tumor Presenting with Arthritis and Panniculitis
      Hyung Rae Kim, Jae-Sung Ahn, Jin-Hee Noh, Hee-jeong Jeon, Ji Seon Oh, Seung Won Choi, Doo-Ho Lim
      Journal of Rheumatic Diseases.2017; 24(5): 313.     CrossRef
    • Predictors of Psychological Distress Trajectories in the First Year After a Breast Cancer Diagnosis
      Jin-Hee Park, Mison Chun, Yong-Sik Jung, Sun Hyoung Bae
      Asian Nursing Research.2017; 11(4): 268.     CrossRef
    • Dietary Factors and Female Breast Cancer Risk: A Prospective Cohort Study
      Ji Kim, Jeonghee Lee, So-Youn Jung, Jeongseon Kim
      Nutrients.2017; 9(12): 1331.     CrossRef
    • Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009
      Kumban Walter Chuck, Minji Hwang, Kui Son Choi, Mina Suh, Jae Kwan Jun, Boyoung Park
      Epidemiology and Health.2017; 39: e2017036.     CrossRef
    • Development of second primary cancer in Korean breast cancer survivors
      Hong Kyu Jung, Suyeon Park, Nam Won Kim, Jong Eun Lee, Zisun Kim, Sun Wook Han, Sung Mo Hur, Sung Young Kim, Cheol Wan Lim, Min Hyuk Lee, Jihyoun Lee
      Annals of Surgical Treatment and Research.2017; 93(6): 287.     CrossRef
    • Comparison of outcomes of surgeon-performed intraoperative ultrasonography-guided wire localization and preoperative wire localization in nonpalpable breast cancer patients undergoing breast-conserving surgery
      Young Duck Shin, Young Jin Choi, Dae Hoon Kim, Sung Su Park, Hanlim Choi, Dong Ju Kim, Sungmin Park, Hyo Yung Yun, Young Jin Song
      Medicine.2017; 96(50): e9340.     CrossRef
    • The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
      Soo-Kyung Cho, Jiyoung Lee, Minkyung Han, Sang-Cheol Bae, Yoon-Kyoung Sung
      Arthritis Research & Therapy.2017;[Epub]     CrossRef
    • Disease-Specific Mortality of Differentiated Thyroid Cancer Patients in Korea: A Multicenter Cohort Study
      Min Ji Jeon, Won Gu Kim, Tae Hyuk Kim, Hee Kyung Kim, Bo Hyun Kim, Hyon-Seung Yi, Eun Sook Kim, Hosu Kim, Young Nam Kim, Eun Heui Kim, Tae Yong Kim, Sun Wook Kim, Ho-Cheol Kang, Jae Hoon Chung, Young Kee Shong, Won Bae Kim
      Endocrinology and Metabolism.2017; 32(4): 434.     CrossRef
    • Clinicopathological Significance of Large Tumor Suppressor (LATS) Expression in Gastric Cancer
      Myoung Won Son, Geum Jong Song, Si-Hyong Jang, Soon Auck Hong, Mee-Hye Oh, Ji-Hye Lee, Moo Jun Baek, Moon Soo Lee
      Journal of Gastric Cancer.2017; 17(4): 363.     CrossRef
    • Thyroid Cancer in Pediatric Age: A Single Institution Experience
      Hyo-Jun Kim, Ji-Won Han, Joong Kee Youn, Hee-Beom Yang, Chaeyoun Oh, Hyun-Young Kim, Sung-Eun Jung, Kwi-Won Park
      Journal of the Korean Association of Pediatric Surgeons.2017; 23(2): 42.     CrossRef
    • Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer
      Wonguen Jung, Kyung Ran Park, Kyung-Ja Lee, Kyubo Kim, Jihae Lee, Songmi Jeong, Yi-Jun Kim, Jiyoung Kim, Hai-Jeon Yoon, Byung-Chul Kang, Hae Soo Koo, Sun Hee Sung, Min-Sun Cho, Sanghui Park
      Radiation Oncology Journal.2017; 35(4): 340.     CrossRef
    • The unrealized potential: cohort effects and age-period-cohort analysis
      Jongho Heo, Sun-Young Jeon, Chang-Mo Oh, Jongnam Hwang, Juhwan Oh, Youngtae Cho
      Epidemiology and Health.2017; 39: e2017056.     CrossRef
    • Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study
      Jae Young Joung, Sung Han Kim, Sohee Kim, Koon Ho Rha, Hyeong Gon Kim, Cheol Kwak, Ji Youl Lee, Seong Soo Jeon, Sung Kyu Hong, Hyeon Jeong, Moon Ki Jo, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Choung-Soo Kim
      Scientific Reports.2017;[Epub]     CrossRef
    • Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
      Jung Han Kim, Hyeong Su Kim, Bum Jun Kim
      Oncotarget.2017; 8(29): 48248.     CrossRef
    • The role of targeted agents in the adjuvant treatment of colon cancer: a meta-analysis of randomized phase III studies and review
      Bum Jun Kim, Jae Ho Jeong, Jung Han Kim, Hyeong Su Kim, Hyun Joo Jang
      Oncotarget.2017; 8(19): 31112.     CrossRef
    • Variations in the bitterness perception-related genes TAS2R38 and CA6 modify the risk for colorectal cancer in Koreans
      Jeong-Hwa Choi, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
      Oncotarget.2017; 8(13): 21253.     CrossRef
    • Detection of somatic variants and EGFR mutations in cell-free DNA from non-small cell lung cancer patients by ultra-deep sequencing using the ion ampliseq cancer hotspot panel and droplet digital polymerase chain reaction
      Jae Sook Sung, Hyon Yong Chong, Nak-Jung Kwon, Hae Mi Kim, Jong Won Lee, Boyeon Kim, Saet Byeol Lee, Chang Won Park, Jung Yoon Choi, Won Jin Chang, Yoon Ji Choi, Sung Yong Lee, Eun Joo Kang, Kyong Hwa Park, Yeul Hong Kim
      Oncotarget.2017; 8(63): 106901.     CrossRef
    • Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
      Byoung Hyuck Kim, Eui Kyu Chie, Kyubo Kim, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang, Sung W. Ha
      Oncotarget.2017; 8(44): 78076.     CrossRef
    • The Effects of Physical Activity and Body Fat Mass on Colorectal Polyp Recurrence in Patients with Previous Colorectal Cancer
      Jihye Park, Jae Hyun Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y. Jeon, Tae Il Kim
      Cancer Prevention Research.2017; 10(8): 478.     CrossRef
    • How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
      Seok Joong Yun, Seon-Kyu Kim, Wun-Jae Kim
      Investigative and Clinical Urology.2016; 57(Suppl 1): S44.     CrossRef
    • Factors Affecting Long Term Survival for Metastatic Gastric Cancer Treated with Chemotherapy
      Seong Kyeong Lim, Kyoungwon Jung, Moo In Park, Jae Hyun Kim, Sung Eun Kim, Won Moon, Seun Ja Park
      The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(2): 97.     CrossRef
    • The clinical utilization of radiation therapy in Korea between 2009 and 2013
      Jin-Kyu Kang, Mi-Sook Kim, Won-Il Jang, Young Seok Seo, Hee Jin Kim, Chul Koo Cho, Hyung Jun Yoo, Eun Kyung Paik, Yu Jin Cha, Hyun Jin Song
      Radiation Oncology Journal.2016; 34(2): 88.     CrossRef
    • Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression
      Gang-Sik Choo, Hae-Nim Lee, Seong-Ah Shin, Hyeong-Jin Kim, Ji-Youn Jung
      Marine Drugs.2016; 14(7): 126.     CrossRef
    • The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition
      Jinfeng Zheng, Shaoxiong Zhao, Xiaolong He, Zhili Zheng, Weibin Bai, Youlin Duan, Shanlin Cheng, Juncai Wang, Xucheng Liu, Gang Zhang
      Biochemical and Biophysical Research Communications.2016; 480(4): 508.     CrossRef
    • Tumor-related leukocytosis is associated with poor radiation response and clinical outcome in uterine cervical cancer patients
      Y. Cho, K.H. Kim, H.I. Yoon, G.E. Kim, Y.B. Kim
      Annals of Oncology.2016; 27(11): 2067.     CrossRef
    • Recent Updates on the Management of Medullary Thyroid Carcinoma
      Bo Hyun Kim, In Joo Kim
      Endocrinology and Metabolism.2016; 31(3): 392.     CrossRef
    • The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort Study
      Bang Wool Eom, Young-Woo Kim, Byung-Ho Nam, Keun Won Ryu, Hyun-Yong Jeong, Young-Kyu Park, Young-Joon Lee, Han-Kwang Yang, Wansik Yu, Jeong-Hwan Yook, Geun Am Song, Sei-Jin Youn, Heung Up Kim, Sung-Hoon Noh, Sung Bae Park, Doo-Hyun Yang, Sung Kim
      Journal of Gastric Cancer.2016; 16(3): 182.     CrossRef
    • Korean Gastric Cancer Association Nationwide Survey on Gastric Cancer in 2014

      Journal of Gastric Cancer.2016; 16(3): 131.     CrossRef
    • Development and Validation of the Korean Version of Hand-Foot Skin Reaction and Quality of Life Questionnaire (HF-QoL-K)
      Se Hyun Nam, Hyun Jin Choi, Woo Dae Kang, Seok Mo Kim, Myong Cheol Lim, Sang-Yoon Park, Jung-Sup Kim, Byoung-Gie Kim, Duk-Soo Bae, Jeong-won Lee, Tae-Joong Kim, Taejong Song
      Journal of Korean Medical Science.2016; 31(12): 1969.     CrossRef
    • Chemotherapy in Advanced Urothelial Carcinoma
      Yun-Sok Ha, Tae-Hwan Kim
      The Korean Journal of Urological Oncology.2016; 14(2): 47.     CrossRef
    • The challenge of screening for early gastric cancer in China
      Liang Zong, Masanobu Abe, Yasuyuki Seto, Jiafu Ji
      The Lancet.2016; 388(10060): 2606.     CrossRef
    • Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity
      Ji Hoon Jeon, Dong Keon Kim, Youngmi Shin, Hee Yeon Kim, Bomin Song, Eun Young Lee, Jong Kwang Kim, Hye Jin You, Heesun Cheong, Dong Hoon Shin, Seong-Tae Kim, Jae-Ho Cheong, Soo Youl Kim, Hyonchol Jang
      Experimental & Molecular Medicine.2016; 48(12): e277.     CrossRef
    • A Case Report of a Mucinous Adenocarcinoma Patient Treated with Korean Medicine after Wedge Resection of the Lung
      Min-na Hong, Hye-lim Park, Jae-hyun Cho, Jin-yong Choi, Go-eun Bae, Chang-woo Han, Seong-ha Park, So-yeon Kim, In Lee, Jin-woo Hong, Jun-yong Choi
      The Journal of Internal Korean Medicine.2016; 37(5): 776.     CrossRef
    • Examination History and Abnormal Thyroid and Breast Lesions According to Residential Distance from Nuclear Power Plants
      Young-Khi Lim
      Journal of Radiation Protection and Research.2016; 41(4): 402.     CrossRef
    • Expression and clinical significance of defensin alpha 6 in colorectal cancer
      Saengjin Park, Taesung Ahn, Hyunyong Lee, Dong Jun Jeong, Hae Il Jeong, Myoung Won Son, Moon Soo Lee, Moo-Jun Baek
      Korean Journal of Clinical Oncology.2016; 12(2): 78.     CrossRef
    • Clinicopathologic characteristics of patients with sporadic colorectal cancer under the age of 30
      Jong Wook Oh, Jung Wook Huh, Yoon Ah Park, Yong Beom Cho, Seong Hyeon Yun, Woo Yong Lee, Hee Cheol Kim
      Korean Journal of Clinical Oncology.2016; 12(2): 67.     CrossRef
    • Development and Evaluation of an Infection Prevention Self-care Application for Cancer Patients with Chemotherapy
      Si Won Park, Jeong Sook Park
      Asian Oncology Nursing.2016; 16(4): 197.     CrossRef
    • Effect of Abdominal Skin Massage and Warming Therapy on the Pain and Anxiety in Breast Cancer Patients who Underwent Hormone Injections
      Jin Hee Jun, Youn Ok Lee, Se-Na Lee
      Asian Oncology Nursing.2016; 16(4): 226.     CrossRef
    • Anxiety and Depression as Predictive Factors for Quality of Life in Patients with Advanced Gastrointestinal Cancer
      JungHwa Chung, Jihyun Kwon, Hyun Kyung Kim, Gawon Ju, Seung Taik Kim, Hye Sook Han
      Asian Oncology Nursing.2016; 16(4): 242.     CrossRef
    • Dietary Changes After Breast Cancer Diagnosis: Associations with Physical Activity, Anthropometry, and Health-related Quality of life Among Korean Breast Cancer Survivors
      Sihan Song, Hyun Jo Youn, So-Youn Jung, Eunsook Lee, Zisun Kim, Jihyoung Cho, Young Bum Yoo, Hyeong-Gon Moon, Dong-Young Noh, Jung Eun Lee
      Korean Journal of Community Nutrition.2016; 21(6): 533.     CrossRef
    • Risk Factors of Postoperative Hypocalcemia after Total Thyroidectomy of Papillary Thyroid Carcinoma Patients
      Ji Young Seong, Cho Rok Lee, Min Jhi Kim, Tae Hyung Kim, Seul Gi Lee, Jung Bum Choi, Eun Jeong Ban, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Cheong Soo Park
      Korean Journal of Endocrine Surgery.2016; 16(3): 70.     CrossRef
    • Risk Factors of Postoperative Hypocalcemia after Total Thyroidectomy of Papillary Thyroid Carcinoma Patients
      Ji Young Seong, Cho Rok Lee, Min Jhi Kim, Tae Hyung Kim, Seul Gi Lee, Jung Bum Choi, Eun Jeong Ban, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Cheong Soo Park
      Korean Journal of Endocrine Surgery.2016; 16(3): 70.     CrossRef
    • 3,3’-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and –independent prostate cancer cells
      Alexander A. Goldberg, Hossam Draz, Diana Montes-Grajales, Jesus Olivero-Verbél, Stephen H. Safe, J. Thomas Sanderson
      Genes & Cancer.2015; 6(5-6): 265.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
      Cancer Res Treat. 2016;48(2):436-450.   Published online March 3, 2016
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    • 2
    • 3
    • 4
    • 5
    Related articles
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
    Image Image Image Image Image Image
    Fig. 1. Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2013 in Korea. Age standardization was based on the Segi’s world standard population.
    Fig. 2. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2013 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 3. Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2013 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 4. Age-specific incidence rates of common cancers for 2013 in Korea. (A) Men. (B) Women.
    Fig. 5. Trends in relative survival by year of diagnosis from 1999 to 2013. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
    Fig. 6. Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2014 among all cancer patients diagnosed between 1999 and 2013.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
    Site/Type New cases
    Deaths
    Prevalent casesa)
    Both sexes Male Female Both sexes Male Female Both sexes Male Female
    All sites 225,343 113,744 111,599 75,334 47,079 28,255 1,370,049 603,524 766,525
    Lip, oral cavity, and pharynx 3,041 2,181 860 1,078 821 257 18,539 12,476 6,063
    Esophagus 2,382 2,186 196 1,448 1,320 128 8,090 7,321 769
    Stomach 30,184 20,266 9,918 9,180 5,995 3,185 224,352 148,926 75,426
    Colon and rectum 27,618 16,593 11,025 8,199 4,659 3,540 190,094 113,547 76,547
    Liver 16,192 12,105 4,087 11,405 8,421 2,984 55,049 41,203 13,846
    Gallbladderb) 5,283 2,707 2,576 3,783 1,874 1,909 16,021 8,195 7,826
    Pancreas 5,511 2,982 2,529 4,831 2,615 2,216 7,757 4,185 3,572
    Larynx 1,196 1,116 80 403 369 34 9,149 8,592 557
    Lung 23,177 16,171 7,006 17,177 12,519 4,658 58,653 37,399 21,254
    Breast 17,292 61 17,231 2,244 13 2,231 147,012 596 146,416
    Cervix uteri 3,633 - 3,633 892 - 892 45,989 - 45,989
    Corpus uteri 2,212 - 2,212 248 - 248 17,053 - 17,053
    Ovary 2,236 - 2,236 1,038 - 1,038 15,362 - 15,362
    Prostate 9,515 9,515 - 1,629 1,629 - 55,756 55,756 -
    Testis 254 254 - 19 19 - 2,440 2,440 -
    Kidney 4,333 2,992 1,341 937 664 273 29,069 19,621 9,448
    Bladder 3,762 3,025 737 1,280 975 305 27,440 22,360 5,080
    Brain and CNS 1,813 941 872 1,196 625 571 9,302 4,828 4,474
    Thyroid 42,541 8,454 34,087 393 120 273 300,851 49,119 251,732
    Hodgkin lymphoma 262 169 93 63 41 22 2,194 1,401 793
    Non-Hodgkin lymphoma 4,828 2,668 2,160 1,581 929 652 29,347 15,797 13,550
    Multiple myeloma 1,327 694 633 804 437 367 4,325 2,256 2,069
    Leukemia 3,011 1,716 1,295 1,593 945 648 16,309 9,002 7,307
    Other and ill-defined 13,740 6,948 6,792 3,913 2,089 1,824 79,896 38,504 41,392
    Site/Type Crude incidence rate per 100,000
    Age-standardized incidence rate per 100,000a)
    Both sexes Male Female Both sexes Male Female
    All sites 445.7 449.9 441.5 290.5 316.5 281.8
    Lip, oral cavity, and pharynx 6.0 8.6 3.4 4.0 6.0 2.2
    Esophagus 4.7 8.6 0.8 2.9 6.0 0.4
    Stomach 59.7 80.2 39.2 37.4 55.3 22.4
    Colon and rectum 54.6 65.6 43.6 34.0 45.6 24.4
    Liver 32.0 47.9 16.2 20.2 32.8 9.0
    Gallbladderb) 10.4 10.7 10.2 6.1 7.4 5.0
    Pancreas 10.9 11.8 10.0 6.6 8.2 5.2
    Larynx 2.4 4.4 0.3 1.5 3.1 0.2
    Lung 45.8 64.0 27.7 27.4 44.2 14.9
    Breast 34.2 0.2 68.2 23.0 0.2 45.7
    Cervix uteri 7.2 - 14.4 4.8 - 9.5
    Corpus uteri 4.4 - 8.8 2.9 - 5.8
    Ovary 4.4 - 8.8 3.1 - 6.0
    Prostate 18.8 37.6 - 11.4 26.2 -
    Testis 0.5 1.0 - 0.5 1.0 -
    Kidney 8.6 11.8 5.3 5.7 8.3 3.4
    Bladder 7.4 12.0 2.9 4.4 8.3 1.4
    Brain and CNS 3.6 3.7 3.4 2.9 3.2 2.7
    Thyroid 84.1 33.4 134.9 60.1 24.0 96.6
    Hodgkin lymphoma 0.5 0.7 0.4 0.4 0.6 0.3
    Non-Hodgkin lymphoma 9.5 10.6 8.5 6.7 8.0 5.6
    Multiple myeloma 2.6 2.7 2.5 1.6 1.9 1.4
    Leukemia 6.0 6.8 5.1 5.0 6.0 4.2
    Other and ill-defined 27.2 27.5 26.9 17.8 20.5 15.6
    Rank Cause of death No. of deaths Percentage of all deaths Age-standardized death rate per 100,000a)
    All causes 266,257 100.0 309.4
    1 Cancer 75,334 28.3 87.9
    2 Cerebrovascular disease 25,447 9.6 27.0
    3 Heart disease 25,365 9.5 27.9
    4 Intentional self-harm (suicide) 14,427 5.4 20.3
    5 Diabetes mellitus 10,888 4.1 11.6
    6 Pneumonia 10,809 4.1 11.2
    7 Chronic lower respiratory diseases 7,074 2.7 7.3
    8 Disease of liver 6,665 2.5 8.3
    9 Transport accidents 6,028 2.3 8.7
    10 Hypertensive diseases 4,732 1.8 4.9
    Others 79,488 29.9 94.4
    Site/Type Crude mortality rate per 100,000
    Age-standardized mortality rate per 100,000a)
    Both sexes Male Female Both sexes Male Female
    All sites 149.0 186.2 111.8 87.9 130.1 57.5
    Lip, oral cavity, and pharynx 2.1 3.2 1.0 1.3 2.3 0.5
    Esophagus 2.9 5.2 0.5 1.7 3.6 0.3
    Stomach 18.2 23.7 12.6 10.5 16.4 6.1
    Colon and rectum 16.2 18.4 14.0 9.3 12.9 6.7
    Liver 22.6 33.3 11.8 13.8 22.9 6.1
    Gallbladderb) 7.5 7.4 7.6 4.2 5.2 3.5
    Pancreas 9.6 10.3 8.8 5.6 7.2 4.4
    Larynx 0.8 1.5 0.1 0.4 1.0 0.1
    Lung 34.0 49.5 18.4 19.3 34.0 8.8
    Breast 4.4 0.1 8.8 2.9 0.0 5.6
    Cervix uteri 1.8 - 3.5 1.1 - 1.9
    Corpus uteri 0.5 - 1.0 0.3 - 0.6
    Ovary 2.1 - 4.1 1.3 - 2.4
    Prostate 3.2 6.4 - 1.7 4.8 -
    Testis 0.0 0.1 - 0.0 0.1 -
    Kidney 1.9 2.6 1.1 1.1 1.8 0.5
    Bladder 2.5 3.9 1.2 1.4 2.8 0.5
    Brain and CNS 2.4 2.5 2.3 1.7 2.0 1.5
    Thyroid 0.8 0.5 1.1 0.4 0.3 0.5
    Hodgkin lymphoma 0.1 0.2 0.1 0.1 0.1 0.1
    Non-Hodgkin lymphoma 3.1 3.7 2.6 1.9 2.6 1.3
    Multiple myeloma 1.6 1.7 1.5 0.9 1.2 0.8
    Leukemia 3.2 3.7 2.6 2.2 2.9 1.6
    Other and ill-defined 7.7 8.3 7.2 4.7 6.0 3.8
    Site/Type Year
    APC
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    All sites 210.5 205.1 216.7 220.1 227.9 235.1 247.9 252.2 263.5 276.1 286.9 293.5 303.8 301.7 290.5 3.1a)
    Lip, oral cavity, and pharynx 3.6 4.4 3.6 3.7 3.8 3.8 3.8 3.8 3.9 4.0 3.8 4.0 4.1 4.0 4.0 0.4
    Esophagus 4.1 3.7 3.9 3.8 3.6 3.6 3.5 3.4 3.3 3.3 3.1 3.1 3.0 3.0 2.9 –2.2a)
    Stomach 43.6 42.3 44.0 43.6 43.3 41.2 44.4 42.8 41.8 42.6 43.4 42.5 42.8 40.1 37.4 -0.6
    Colon and rectum 20.4 21.0 22.9 24.7 26.9 28.6 31.0 32.5 33.8 34.9 36.9 36.9 38.3 37.7 34.0 4.6a)
    Liver 27.9 26.7 27.3 26.5 25.7 25.6 25.8 24.6 24.4 24.1 23.5 22.8 22.5 21.2 20.2 –2.0a)
    Gallbladderb) 6.5 6.4 6.7 6.7 6.7 6.9 7.1 6.6 6.6 6.4 6.8 6.6 6.4 6.3 6.1 –0.3
    Pancreas 5.6 5.5 5.5 5.8 5.9 6.0 6.3 6.2 6.3 6.4 6.3 6.4 6.7 6.8 6.6 1.5a)
    Larynx 2.3 2.2 2.4 2.2 2.1 1.9 2.0 1.8 1.8 1.7 1.7 1.6 1.5 1.4 1.5 –3.5a)
    Lung 28.5 27.7 28.3 28.5 27.9 28.8 29.0 28.7 28.4 28.2 28.3 28.6 28.7 27.7 27.4 –0.1
    Breast 10.7 10.8 12.7 13.9 14.3 15.0 16.3 17.0 18.1 18.9 19.7 20.7 22.3 22.7 23.0 5.8a)
    Cervix uteri 8.5 7.9 8.3 7.7 7.4 6.9 6.5 6.4 5.7 5.9 5.5 5.6 5.2 4.9 4.8 –4.1a)
    Corpus uteri 1.4 1.3 1.5 1.7 1.9 1.9 2.0 2.1 2.2 2.4 2.6 2.6 2.7 2.7 2.9 5.6a)
    Ovary 2.7 2.5 2.5 2.6 2.7 2.7 2.8 2.8 3.1 2.9 2.8 3.0 3.0 3.1 3.1 1.4a)
    Prostate 3.1 2.7 3.6 3.9 4.8 6.0 6.3 7.3 8.6 9.8 10.6 11.0 11.9 11.7 11.4 12.0a)
    Testis 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.5 0.5 4.6a)
    Kidney 3.0 2.9 3.3 3.4 3.5 3.7 4.1 4.4 4.8 5.1 5.2 5.3 5.6 5.6 5.7 5.5a)
    Bladder 4.6 4.6 4.9 4.7 5.1 5.1 5.1 4.9 5.0 4.8 4.6 4.7 4.7 4.4 4.4 –0.5
    Brain and CNS 2.9 2.8 2.8 2.6 2.9 2.9 3.0 2.9 3.1 3.1 3.0 3.1 2.7 2.9 2.9 0.4
    Thyroid 6.3 6.1 7.9 9.5 12.8 17.3 20.7 25.5 32.9 41.4 48.2 53.7 59.2 63.2 60.1 20.8a)
    Hodgkin lymphoma 0.2 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.4 0.4 0.4 0.4 0.5 0.5 0.4 4.7a)
    Non-Hodgkin lymphoma 4.5 4.2 4.5 4.6 5.0 5.3 5.3 5.5 5.6 5.7 6.2 6.2 6.6 6.7 6.7 3.5a)
    Multiple myeloma 1.0 1.0 1.1 1.1 1.1 1.2 1.3 1.3 1.4 1.4 1.5 1.5 1.4 1.6 1.6 3.6a)
    Leukemia 4.7 4.3 4.7 4.8 4.8 4.8 4.7 4.9 4.9 5.0 5.1 5.0 5.2 5.0 5.0 0.9a)
    Other and ill-defined 14.3 13.5 13.9 13.5 15.2 15.3 16.2 16.2 17.3 17.1 17.2 17.6 18.3 17.9 17.8 2.3a)
    Site/Type Year
    APC
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    All sites 285.0 276.7 288.3 290.0 295.1 299.6 311.4 310.3 317.1 324.2 330.9 332.0 337.2 329.1 316.5 1.3a)
    Lip, oral cavity, and pharynx 6.1 7.1 6.0 6.2 6.5 6.2 6.1 6.2 6.3 6.5 6.1 6.1 6.4 6.2 6.0 –0.2
    Esophagus 8.8 8.0 8.3 8.2 7.7 7.7 7.6 7.2 7.0 7.0 6.6 6.5 6.3 6.1 6.0 –2.6a)
    Stomach 66.2 65.0 67.2 66.6 66.0 62.3 66.9 65.3 63.1 64.5 65.0 63.4 63.8 59.6 55.3 –0.8a)
    Colon and rectum 26.2 27.2 29.6 32.9 35.3 38.0 41.2 43.3 45.3 47.0 50.0 50.1 52.0 50.4 45.6 5.0a)
    Liver 46.8 44.7 45.1 43.9 42.3 42.1 42.6 40.3 39.8 39.5 38.2 36.9 36.1 34.5 32.8 –2.2a)
    Gallbladderb) 8.1 7.8 8.2 8.1 7.8 8.4 8.7 8.1 7.9 7.6 8.1 8.2 7.7 7.6 7.4 –0.4
    Pancreas 7.8 7.6 7.6 7.9 7.7 8.0 8.3 8.0 8.2 8.4 8.1 8.1 8.6 8.5 8.2 0.7a)
    Larynx 4.9 4.5 5.1 4.7 4.5 4.1 4.3 3.8 3.8 3.5 3.6 3.4 3.2 3.0 3.1 –3.6a)
    Lung 51.4 49.8 51.1 51.0 50.0 50.8 50.9 49.2 48.8 47.7 47.5 47.5 46.7 44.7 44.2 –1.0a)
    Breast 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.2 0.2 0.2 0.2 –1.4
    Prostate 8.4 7.2 9.5 10.1 12.5 15.2 15.8 18.0 20.9 23.5 25.3 26.1 27.7 27.3 26.2 10.7a)
    Testis 0.6 0.5 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.7 0.8 0.8 0.9 0.9 1.0 4.5a)
    Kidney 4.5 4.4 4.9 5.0 5.2 5.5 6.0 6.5 7.1 7.5 7.6 8.0 8.1 8.3 8.3 5.2a)
    Bladder 9.0 9.0 9.4 9.0 9.7 9.8 9.8 9.6 9.5 9.2 8.7 8.9 8.9 8.3 8.3 –0.7a)
    Brain and CNS 3.2 3.1 3.1 2.9 3.3 3.3 3.3 3.2 3.4 3.4 3.5 3.5 3.0 3.3 3.2 0.5
    Thyroid 2.1 1.9 2.4 2.7 3.7 4.8 5.9 7.5 10.0 13.3 15.6 18.6 20.4 23.3 24.0 22.7a)
    Hodgkin lymphoma 0.4 0.4 0.4 0.3 0.4 0.5 0.4 0.4 0.5 0.5 0.5 0.6 0.6 0.6 0.6 3.9a)
    Non-Hodgkin lymphoma 5.8 5.5 5.8 5.8 6.2 6.6 6.5 6.9 7.0 6.8 7.5 7.4 7.7 7.9 8.0 2.7a)
    Multiple myeloma 1.2 1.3 1.4 1.4 1.4 1.4 1.6 1.5 1.6 1.7 1.9 1.8 1.8 2.0 1.9 3.3a)
    Leukemia 5.5 5.0 5.4 5.8 5.5 5.7 5.6 5.6 5.7 5.8 5.9 6.0 6.1 5.9 6.0 1.0a)
    Other and ill-defined 17.9 16.5 16.8 16.5 18.5 18.3 19.3 18.9 20.4 19.8 20.0 19.9 20.9 20.3 20.5 1.6a)
    Site/Type Year
    APCa)
    1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
    All sites 161.1 157.4 169.0 174.6 184.6 193.9 208.1 216.7 232.5 249.9 263.9 275.5 290.3 292.9 281.8 5.1a)
    Lip, oral cavity, and pharynx 1.6 2.4 1.7 1.7 1.7 1.9 1.9 1.8 1.9 1.9 1.8 2.2 2.1 2.0 2.2 1.3
    Esophagus 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.5 0.5 0.5 0.4 0.4 0.4 0.5 0.4 –2.2a)
    Stomach 26.7 25.2 26.2 26.3 25.9 24.7 26.8 25.1 24.8 25.1 25.8 25.4 25.3 23.7 22.4 –0.7a)
    Colon and rectum 16.4 16.4 17.9 18.8 20.5 21.5 23.0 24.1 24.6 25.2 26.3 26.1 26.8 27.1 24.4 3.7a)
    Liver 12.3 11.8 12.2 11.8 11.5 11.3 11.4 11.1 11.1 10.7 10.6 10.4 10.5 9.6 9.0 –1.8a)
    Gallbladderb) 5.3 5.5 5.7 5.8 5.8 5.9 6.0 5.5 5.6 5.5 5.8 5.4 5.5 5.3 5.0 –0.5
    Pancreas 4.0 4.0 4.0 4.2 4.4 4.5 4.7 4.7 4.8 4.9 4.9 5.0 5.1 5.4 5.2 2.2a)
    Larynx 0.4 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.2 –7.0a)
    Lung 12.4 12.5 12.3 12.6 12.4 13.0 13.5 14.0 14.0 14.2 14.2 14.8 15.4 15.1 14.9 1.7a)
    Breast 20.9 20.9 24.7 27.2 27.9 29.4 32.1 33.3 35.7 37.3 38.8 40.8 44.1 44.9 45.7 5.9a)
    Cervix uteri 16.3 15.1 15.8 14.8 14.2 13.2 12.4 12.2 11.1 11.5 10.7 10.9 10.2 9.6 9.5 –3.9a)
    Corpus uteri 2.8 2.6 3.0 3.3 3.8 3.7 3.9 4.0 4.2 4.7 5.1 5.1 5.3 5.4 5.8 5.8a)
    Ovary 5.0 4.8 4.8 5.0 5.2 5.2 5.5 5.4 5.9 5.6 5.4 5.9 5.8 6.1 6.0 1.7a)
    Kidney 1.7 1.8 1.9 2.0 2.1 2.2 2.5 2.7 2.8 3.0 3.2 3.0 3.4 3.2 3.4 5.4a)
    Bladder 1.6 1.6 1.7 1.7 1.8 1.7 1.7 1.6 1.7 1.6 1.6 1.5 1.5 1.4 1.4 –1.1a)
    Brain and CNS 2.6 2.5 2.5 2.4 2.6 2.6 2.8 2.7 2.8 2.7 2.6 2.7 2.5 2.4 2.7 0.2
    Thyroid 10.4 10.1 13.2 16.2 21.9 29.6 35.4 43.4 55.7 69.6 80.8 89.0 98.3 103.5 96.6 20.6a)
    Hodgkin lymphoma 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 5.7a)
    Non-Hodgkin lymphoma 3.4 3.2 3.4 3.5 4.0 4.1 4.4 4.4 4.4 4.8 5.2 5.2 5.6 5.7 5.6 4.4a)
    Multiple myeloma 0.8 0.8 0.9 0.8 1.0 1.0 1.2 1.1 1.2 1.2 1.2 1.3 1.1 1.4 1.4 4.1a)
    Leukemia 3.9 3.8 4.1 4.0 4.1 4.1 4.0 4.4 4.2 4.3 4.3 4.1 4.5 4.1 4.2 0.7a)
    Other and ill-defined 11.8 11.5 11.8 11.5 12.9 13.2 13.9 14.2 14.9 15.0 14.9 15.8 16.2 15.9 15.6 2.7a)
    Rank Age (yr)
    0-14 15-34 35-64 ≥ 65
    Male
     1 Leukemia (4.3) Thyroid (17.7) Stomach (88.3) Lung (449.4)
     2 Non-Hodgkin lymphoma (2.4) Leukemia (3.5) Colon and rectum (69.5) Stomach (396.3)
     3 Brain and CNS (2.0) Colon and rectum (3.2) Liver (62.4) Colon and rectum (333.4)
     4 Liver (0.4) Non-Hodgkin lymphoma (3.0) Thyroid (54.6) Prostate (289.3)
     5 Testis (0.4) Stomach (2.3) Lung (42.4) Liver (192.1)
    Female
     1 Leukemia (3.4) Thyroid (71.7) Thyroid (228.2) Colon and rectum (176.5)
     2 Brain and CNS (1.9) Breast (10.6) Breast (123.9) Stomach (149.3)
     3 Non-Hodgkin lymphoma (1.1) Cervix uteri (5.5) Colon and rectum (40.8) Lung (126.6)
     4 Thyroid (0.6) Stomach (3.4) Stomach (38.8) Thyroid (92.7)
     5 Ovary (0.6) Ovary (3.1) Lung (21.7) Liver (72.5)
    Site/Type Both sexes
    Male
    Female
    1993-1995 1996-2000 2001-2005 2008-2013 Changea) 1993-1995 1996-2000 2001-2005 2008-2013 Changea) 1993-1995 1996-2000 2001-2005 2009-2013 Changea)
    All sites 41.2 44.0 53.8 69.4 28.2 31.7 35.3 45.3 61.0 29.3 53.4 55.3 64.0 77.7 24.3
    Lip, oral cavity, and pharynx 41.1 46.7 54.2 63.1 22.0 35.8 41.1 49.4 59.3 23.5 58.1 63.8 67.7 73.0 14.9
    Esophagus 12.7 15.2 21.2 33.4 20.7 11.8 14.3 20.5 33.1 21.3 23.7 24.2 29.6 36.1 12.4
    Stomach 42.8 46.6 57.7 73.1 30.3 43.0 46.9 58.4 73.9 30.9 42.6 46.0 56.4 71.5 28.9
    Colon and rectum 54.8 58.0 66.6 75.6 20.8 55.3 59.0 68.5 77.5 22.2 54.2 56.8 64.2 72.6 18.4
    Liver 10.7 13.2 20.2 31.4 20.7 9.9 12.9 20.2 31.6 21.7 13.6 14.2 20.4 30.8 17.2
    Gallbladderb) 17.3 19.7 22.8 29.0 11.7 16.6 20.3 23.3 30.2 13.6 18.0 19.1 22.3 27.9 9.9
    Pancreas 9.4 7.6 8.2 9.4 - 8.8 7.3 8.2 9.2 0.4 10.1 8.1 8.1 9.7 –0.4
    Larynx 59.7 62.3 66.2 73.1 13.4 60.2 62.8 66.8 73.5 13.3 55.4 57.8 58.2 66.9 11.5
    Lung 11.3 12.7 16.2 23.5 12.2 10.4 11.6 15.0 20.5 10.1 14.2 16.2 19.7 30.6 16.4
    Breast 77.9 83.2 88.5 91.5 13.6 75.1 85.6 87.0 91.6 16.5 78.0 83.2 88.5 91.5 13.5
    Cervix uteri 77.5 80.0 81.3 80.1 2.6 - - - - - 77.5 80.0 81.3 80.1 2.6
    Corpus uteri 81.5 81.8 84.6 87.9 6.4 - - - - - 81.5 81.8 84.6 87.9 6.4
    Ovary 58.7 58.9 61.4 62.0 3.3 - - - - - 58.7 58.9 61.4 62.0 3.3
    Prostate 55.9 67.2 80.2 92.5 36.6 55.9 67.2 80.2 92.5 36.6 - - - - -
    Testis 85.4 90.4 90.6 94.9 9.5 85.4 90.4 90.6 94.9 9.5 - - - - -
    Kidney 62.0 66.1 73.4 80.8 18.8 60.8 64.4 72.8 80.5 19.7 64.5 69.7 74.5 81.6 17.1
    Bladder 69.1 73.1 75.6 75.3 6.2 70.0 74.8 77.4 77.4 7.4 65.5 66.3 68.5 67.0 1.5
    Brain and CNS 38.5 39.0 40.7 41.8 3.3 37.2 37.5 40.1 40.1 2.9 40.2 40.7 41.4 43.9 3.7
    Thyroid 94.2 94.9 98.3 100.2 6.0 87.2 89.5 95.8 100.6 13.4 95.4 95.9 98.7 100.1 4.7
    Hodgkin lymphoma 68.0 71.2 76.6 78.2 10.2 67.6 68.1 74.6 78.6 11.0 68.6 77.4 80.7 77.5 8.9
    Non-Hodgkin lymphoma 46.6 50.8 60.0 68.4 21.8 45.3 48.9 58.1 66.6 21.3 48.7 53.5 62.4 70.5 21.8
    Multiple myeloma 22.1 19.8 29.3 38.9 16.8 21.1 17.8 29.6 37.6 16.5 23.3 22.1 29.0 40.5 17.2
    Leukemia 26.5 33.3 41.8 49.7 23.2 26.2 32.3 41.7 49.7 23.5 26.8 34.6 42.0 49.6 22.8
    Other and ill-defined 42.1 45.9 55.9 68.1 26.0 37.4 42.4 52.2 64.6 27.2 47.4 50.0 60.0 71.7 24.3
    Site/Type Crude prevalence rate per 100,000a)
    Age-standardized prevalence rate per 100,000b)
    Both sexes Male Female Both sexes Male Female
    All sites 2,709.8 2,387.1 3,032.6 1,772.4 1,683.6 1,944.3
    Lip, oral cavity, and pharynx 36.7 49.3 24.0 24.3 34.7 15.3
    Esophagus 16.0 29.0 3.0 9.9 20.0 1.7
    Stomach 443.7 589.0 298.4 276.0 405.3 169.9
    Colon and rectum 376.0 449.1 302.8 232.6 311.2 169.7
    Liver 108.9 163.0 54.8 71.1 113.2 33.2
    Gallbladderc) 31.7 32.4 31.0 19.0 22.3 16.5
    Pancreas 15.3 16.6 14.1 9.7 11.6 8.2
    Larynx 18.1 34.0 2.2 11.2 23.6 1.2
    Lung 116.0 147.9 84.1 71.8 102.7 48.1
    Breast 290.8 2.4 579.3 191.6 1.6 376.3
    Cervix uteri 91.0 - 181.9 59.1 - 115.0
    Corpus uteri 33.7 - 67.5 22.6 - 44.2
    Ovary 30.4 - 60.8 21.6 - 42.7
    Prostate 110.3 220.5 - 63.1 152.1 -
    Testis 4.8 9.7 - 4.4 8.6 -
    Kidney 57.5 77.6 37.4 38.2 54.5 23.9
    Bladder 54.3 88.4 20.1 32.2 61.4 10.1
    Brain and CNS 18.4 19.1 17.7 15.9 16.9 14.8
    Thyroid 595.0 194.3 995.9 409.6 135.5 681.9
    Hodgkin lymphoma 4.3 5.5 3.1 3.6 4.6 2.7
    Non-Hodgkin lymphoma 58.0 62.5 53.6 41.9 47.7 36.7
    Multiple myeloma 8.6 8.9 8.2 5.4 6.1 4.8
    Leukemia 32.3 35.6 28.9 30.6 34.2 27.0
    Other and ill-defined 158.0 152.3 163.8 107.2 115.8 100.2
    Table 1. Cancer incidence, deaths and prevalence by sex in Korea, 2013

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2014. These are patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 2. Crude and age-standardized cancer incidence rates by sex in Korea, 2013

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3. The top 10 leading causes of death in Korea, 2013

    Source: Mortality Data, 2013, Statistics Korea [8].

    Age-adjusted using the world standard population.

    Table 4. Crude and age-standardized cancer mortality rates by sex in Korea, 2013

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5. Trends in cancer incidence rates for both sexes from 1999 to 2013 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6. Trends in cancer incidence rates in men from 1999 to 2013 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7. Trends in cancer incidence rates in women from 1999 to 2013 in Korea

    APC was calculated using age-standardized incidence data based on the world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 8. The five common sites of cancer incidence by age group and sex in Korea, 2013

    CNS, central nervous system.

    Table 9. Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2013 in Korea

    CNS, central nervous system.

    Percentage change in 5-year relative survival from 1993 to 1995 and 2009 to 2013,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 10. Crude and age-standardized rates of cancer prevalence by sex on January 1, 2014 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2013 and who were alive on January 1, 2014. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP